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INTRODUCTION 
Men having Sex with Men(MSM) are male persons who engage in 
sexual activity with members of the same sex, regardless of how they 
identify themselves. The term was created in the 1990s by 
epidemiologists to study the spread of disease among men who have sex 
with men. 
The Huffington Post postulates that the term MSM was created by 
Cleo Manago, the man who is also credited for coining the term same 
gender loving (SGL). 
To describe a person as ―homosexual (MSM)‖can have 3 rather 
subtly different meanings: 
1) It can describe a person‘s behavior  
2) It can describe a person‘s preference  
3) It can describe a person‘s identity 
Men who have sex with men (MSMs) are a vulnerable population 
for spread of sexually transmitted infections. They tend to have a 
different distribution patterns of STIs(sexually transmitted infections).  
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Men who have sex with men (MSM) face significant healthcare-
related stigma which manifests as a barrier to the uptake of routine 
services including screening for sexually transmitted infections (STIs). 
MSM are classified into different categories based on identity, 
gender, behavior, and profession. Based on identity they are categorized 
as "gay," "Kothis," (receptive partner) or "Panthis" (insertive partners), 
―double deckers‖( both insertive and receptive). There are MSM who do 
not identify with queer labels but are homosexual or bisexual 
behaviorally. 
Identification of MSMs is important as most of them are bisexual 
and promiscuous , thereby playing a role in spread of STDs in a vast 
number of partners. The profile of STDs also differs in MSM which 
makes it all the more important to identify them 
Factors leading to high prevalence of STIs among MSM are  
1) BIOLOGICAL FACTORS: unprotected anal intercourse carries a 
higher risk of transmission than vaginal intercourse(45-55% of 
MSM in India practice anal sex) 
2) BEHAVIOURAL FACTORS: multiple sexual partners, less 
condom usage(5-20%), unawareness about infections, alcohol and 
drugs, poor health-seeking behavior, with only 20-30% of MSM 
going for STI checkup 
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3) SOCIAL AND CULTURAL FACTORS: fear of their sexual 
orientation and identity being revealed in society leads to less 
access to health services. 
The overall median seroreactivity among MSM for syphilis is 
10% and for HIV is 12% 
MSMs are one of the risk group targeted by National AIDS 
Control Organization (NACO) to reduce human immunodeficiency virus 
(HIV) transmission. NACO estimates that India is home to 2.5 million 
MSMs of which 100,000 are at high risk of contracting HIV due to 
multipartner and commercial sexual practices. Already, 15% of this 
community is infected with this disease 
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AIMS AND OBJECTIVE 
The objective of this study is to characterize the prevalence and 
pattern of STIs in this population to provide insight into appropriate STI 
screening and management guidelines for this population. 
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REVIEW OF LITERATURE 
HUMAN SEXUAL BEHAVIOUR 
Human Sexual behavior refers to a broad spectrum of behaviors in 
which humans display their sexuality. These behavioral expressions 
contains both biological elements and cultural influences and involves 
sexual arousal (with its physiological changes, both pronounced and 
subtle, in the aroused person). Sexual behavior ranges from the solitary 
(such as masturbation and autoerotic stimulation) to partnered sex 
(intercourse, oral sex, non-penetrative sex, etc.) that is engaged 
periodically. Sexual behavior can also involve behavior that is aimed at 
arousing desire in potential partners (courtship displays or rituals) or 
behavior aimed at enhancing sexual experiences.  
PSYCHOLOGICAL THEORIES OF HUMAN SEXUALITY  
Sexual behavior is considered as an inborn drive in the humans: it 
is even seen in infants. Sex drive is modified by social, cultural and 
interpersonal factors. Freud‘s stages included the oral stage, the anal 
stage,the genital stage,the latency stage,and the reawakening of sexual 
impulses at puberty.The fundamental propensity to act sexually exists in 
general but that it may be modified by learning. The specific 
development of heterosexual or homosexual behavior results from the 
interaction of biological and social factors. Sexuality has a number of 
different aspects and meanings depending on variation in person, time, 
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culture, age, and situation. Sexuality is not a unitary phenomenon but 
part of social interaction and best explained by opportunity and 
contingencies of reinforcement acting upon a basic biological drive.  
The sexual behavior is strongly channelized into particular 
patterns which is consistent  and matches with their particular cultural 
backgrounds.Because of this cultural backgrounds , every individual is 
subjected to strong pressures to stick on to the traditional sexual 
behavior patterns which are being followed and practiced by hundreds or 
thousands of years of cultural heritage. 
Human sexual behavior should be viewed with three aspects in 
mind: the biological factors, the learning processes ,  and finally the 
sociocultural environment. Since huge cultural variation exists between 
different groups of people in different places in the world, leads on to 
the large variations in sexual behavior in different civilizations all over 
the world. 
CONCEPT OF SEXUAL DEVIANCE 
Deviance is the behavior that contravenes the norms and culture 
of the society. These norms include both institutionalized norms and the 
shred norms. It is defined in terms of statistical abnormality or of 
psycho-pathology. The criteria which is used to define psychopathology 
is medical rationalization of the social criteria. A typical and most 
common example for this is ―homosexuality‖. Because of the 
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sociological defination of human sexual behavior , these individuals will 
have  social stigma, which plays important negative role in the lives of 
these deviants ( homosexuals). 
Gagon et al
1
 proposed a distinction between 3 types of deviance. 
1) ―normal deviance‖ this includes the behaviors such as masturbation , 
premariatal sex and oro-genital sex. The other two types of deviance 
distinguish between behaviours which are associated with particular 
subculture (such as homosexual subcultures) called ―subcultu ral 
deviances‖ and those which are not ( such as exhibitionism or incest) 
called as ―individual deviances‖. This categorization helps the 
individual to have a social group in which he feels normal.  
SEXUAL ORIENTATION 
Sexual orientation refers to the erotic and/or affectional 
disposition to the same and/or opposite sex.―Orientation‖rather than 
―preference‖ is used because most individuals do not experience having 
ever had a choice about being attracted to women or men. The terms 
most commonly employed to refer to sexual orientation are 
heterosexual,  homosexual ,and bisexual.  
HOMOSEXUALITY 
Male homosexual behavior has been denounced in the Old 
Testament and extolled by classical Greek poets like Hesiod, 
underscoring the longstanding awareness that these behaviors have been 
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commonly expressed since the beginning of human civilization, and 
demonstrating the ways that diverse cultures have grappled with 
deviations from the heterosexual norm
2
. Although the Bible 
recommended that men and women who engaged in homosexual 
intercourse be put to death, justifying this as a crime against nature, 
these behaviors were also associated with sacred rituals of local 
polytheistic cultures, suggesting that neighboring peoples were able to 
accept homosexuality. Although many famous personalities in history—
e.g., Alexander the Great, Tchaikovsky, Walt Whitman—were known to 
prefer homosexual partners, until the landmark studies of Kinsey and 
colleagues, very little was known about the natural history and 
prevalence of male homosexual behavior
3
. Kinsey et al. examined the 
life histories of more than 6300 males and found that 2/3 had engaged in 
some homoerotic play as preadolescents, but only 15% of the events 
involved oral or anal–genital contact. Although the finding that 37% of 
the males had at least one postpubertal homosexual experience is higher 
than the rates reported in subsequent studies. Because of legal and social 
sanctions against the public expression of homosexuality until the 
advent of the sexual revolution of the past 40 years, earlier records of 
sexually transmitted disease (STD) epidemics, such as syphilis in the 
late fifteenth century,are generally not enlightening with regard to the 
extent that male homosexual behavior abetted the spread of specific 
STD pathogens. However, the increased social acceptance of 
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homosexuality in developed countries in the late 1960s and 1970s was 
associated with the development of a subculture that accepted intimacy 
with multiple partners as a normative behavioral pattern
4
. 
To describe a person as ― homosexual‖ can have three different 
meanings: 
1) ―Homosexual‖ can describe a person‘s sexual behavior- i.e., a 
person who predominantly or exclusively has sex with a person or 
persons of the same sex can be said to be homosexual in behavior. 
Many people whose behavior falls into this category do not regard 
themselves as being homosexual; however the term ―men who 
have sex with men‖(MSM) is given to this individuals.  
2) ―Homosexual‖ can describe a person‘s sexual preference - i.e., a 
person whose sexual desire is predominantly directed towards 
members of the same sex can be said to be homosexual in 
orientation. 
3) ―Homosexual‖ can describe a person‘s sexual identity – i.e., a 
person who adopts a sexual life style which is consistent with and 
self-defined by same sex desire and same sex behavior can be said 
to have a homosexual identity. 
It is important to understand and differentiate between the 
concepts of sexual identity, sexual orientation and sexual behavior.  
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Sexual behavior does not  correlate entirely with sexual identity 
and  sexual orientation in many of the cases , but it focuses on the 
description of sexual practices. For example, a married man, self – 
identified him as a heterosexual man, may still get engage in the sexual 
behaviors with other men. Such individual  can be categorized as MSM, 
even though he might not seek such intimacy to be considered as sex in 
his society or culture. However, the term ‗MSM‘ has evolved in many 
parts of India to now take on meanings of identity as well.  
In the Indian subcontinent, the most prominent groups are 
1) HIJRAS – transgendered MSM, sometimes regarded as a ―third 
sex‖. They are often castrated, dress as women and are part of a 
clearly identified social groups, which is tolerated by society but 
sometimes feared as well. 
2) KOTHIS – also called as METIS in Nepal, these are MSM who 
adopt an effeminate (feminine) lifestyle but who nevertheless may 
be married and father of children. 
3) PANTHIS – also called as Ta in Nepal, these are masculine men 
who although passing as ordinary males in the community 
sometimes have insertive sex with Kothis. They do not self -
identity but are labeled or nick-named Panthis by the Kothis. 
4) DOUBLE DECKERS – men who are both receptive and insertive 
partners. 
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There are men who indulge in sex with the men for cash or kind. 
Male sex workers(MSWs) encompasses all these groups.  
In Southeast Asia, there are many groups of MSM, but some of 
the more prominent and better-known ones include: 
1) KOTOEY (Thailand and Laos), 
2) KTEUY (Cambodia) and  
3) WARIA (Indonesia) 
4) SRAY SROS(Cambodia)  
5) PROS SAAT(Cambodia)  
However, these identity labels do not always predict specific 
sexual behavior as male to male sexual practices are often fluid. Other 
men who privately self-identify as homosexual or a gay (often those 
who are educated), may still be having sex with both men and women 
because of family pressures to marry or to have children. Regardless of 
their actions, MSM who engage in high risk sexual behaviors put 
themselves and/or their partners at risk for HIV and other sexual ly 
transmitted infections (STIs). They need to be counselled regarding how 
to engage in sexual behaviors with reduced risk of acquiring or 
transmitting STIs and HIV to themselves or their sexual partners.  
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CULTURE AND SEXUALITY IN INDIA  
Although in Indian culture, heterosexuality has been openly 
considered the norm, there is much evidence, both historical as well as 
recent, showing that men in India have and continue to engage in 
different types of sexual or other relationships. Ancient Indian scriptures 
as well as more secular texts provide evidence of same-sex (i.e. male-
male or female-female) relationships. The Ayurvedic texts, Susruta and 
Charaka Samhitas, dating from the first century detail taxonomies of 
gender and sexual variations, including same-sex desire
5
. Scriptures 
such as the Puranas and Mahabharata among others also provide 
references of same-sex relations and behaviour
6,7,8,9
. The stigma that has 
become attached to such relationships and behaviours, has been 
attributed in part to colonial influences
10,11
, family and community 
attitudes towards marriage and having children. One source of this 
stigma included the addition of section 377 to the Indian penal code by 
the British in 1860, which still exists in Indian law. Colonial influences 
imported a much more repressive attitudes towards sexuality than 
existed in pre-colonial India
10
. This law criminalized same sex 
behaviour and has been an ongoing source of discrimination and 
harassment and has also hindered prevention efforts to combat HIV/ 
AIDS
12-14
. Recently, the Delhi High Court has ruled against section 377, 
which will help HIV prevention efforts, although appeals are ongoing 
and the Supreme Court is now considering the case.  
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Data from many different surveys across the country show that 
same sex activity exists and is prevalent across India in both urban and 
rural areas. Furthermore, MSM are a part of all socio-economic groups 
and span all religious as well as other social groups. One study done in 
several villages reported that nearly 10 per cent of single men and 3 per 
cent of married men engaged in same sex behaviour
15
. Another survey 
showed that 7 per cent of male college students in Chennai had their 
first sexual experience with another male
16
. A different sexual behavior 
survey in Uttar Pradesh reported that approximately 54 per cent of male 
respondents indicated some type of same sex behavior during their 
lifetime
17
. Another study conducted at a drop-in center for MSM in 
Mumbai showed that nearly 23 per cent of MSM were married and that 
being married to a woman was actually associated with a much higher 
risk of being HIV positive (23.8% for married men vs. 9.1% for 
others)
18
. These surveys, as many sexual behaviour surveys are, can be 
problematic for several reasons, since these did not use probability-
based sampling, the true prevalence of these behaviours in Indian 
society is unknown. Another potential bias is the probable under-
reporting of same sex behaviour due to stigma surrounding such 
behaviours and relationships. However, the point  is that same sex 
behaviours in India are prevalent and warrant attention from the medical 
community in delivering appropriate health care.  
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SEXUAL ROLE BEHAVIOR AMONG MSM      
Men negotiate sexual partners in a number of different contexts 
and increasingly through internet. They engage in wide variety of sexual 
practices such as frottage , oro- genital , oro -anal, penile -anal 
intercourse , they may also use unique techniques of sado-masochism, 
water sports , fisting, scatting. ―Barebacking‖ is the term used 
unprotected anal sex without condom usage and this is usually practiced 
by some MSMs who feels that condom usage will reduce the pleasure of 
sex. These sexual practices have more potential for the transmission of 
HIV and other STIs. ―Bug chasers‖ these  are the men who purposefully 
indulge in these kind of high risk practices,wishing to become infected 
by HIV so that they should fit in with friends or to remove concern 
about being infected. 
For homosexual male anal intercourse, individual men can play 
either the insertive or receptive role. Some men consistently perform 
one or the other, while others perform both. This yields three role 
subgroups of men: insertive, receptive and versatile as opposed to the 
two role categories of male and female in heterosexual intercourse. This 
changes population transmission dynamics, and the impact depends on 
the prevalence of each role and the relative transmission probabilities of 
insertive and receptive sex. 
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DESCRIPTIONS OF PARTNERSHIP TYPES 
The types of partnership classifications most often studied in 
STI/HIV research are ―main partner‖ or ―regular partner‖ versus ―casual 
partner‖. The benchmark study of sexuality in the United States, the 
National Health and Social Life Survey (NHSLS), described only four 
types of sexual partnerships: marriage, cohabitation, the intention of one 
or both partners to pursue the relationship further, and the explicit view 
by the partners of the relationship as short term
19
. There are different 
types of partners, for both heterosexuals and MSM. This list in a study 
of MSM recently infected with HIV revealed a large distribution in the 
types of partnerships reported3 and revealed changes in numbers of such 
partners and in the practice of risk behaviors within these partnerships 
following the diagnosis of HIV
20
. 
USE AND NON USE OF PROTECTIVE BEHAVIORS  
Condom use by MSM has long been promoted as the fundamental 
way to prevent STI/HIV transmission among MSM. For example,among 
MSM in 17 U.S. cities, about 58% with a main male partner and by 36% 
with a casual male partner. The pattern is similar for young MSM, with 
even fewer always using condoms with steady partners than with 
nonsteady partners. ―Barebacking‖ has been defined as a phenomenon in 
which some MSM seek unprotected anal sex in spite of and sometimes 
because of the risk of acquiring HIV.Barebacking has been construed as 
anal intercourse without condoms with intention, to be contrasted with 
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just the behavior of anal sex without a condom, and that those who 
bareback share a social identity. Barebacking has been reported more 
often by HIV-positive MSM than by HIV-negative MSM, who often 
reported barebacking with sero-concordant partners. This suggests some 
reduction in transmission risk that may accompany the barebacking 
practiced by some HIV-positive MSM. HIV-positive MSM continue risk 
behavior following their diagnoses and unprotected sex with casual 
partners has been especially common among MSM on highly active 
antiretroviral therapy (HAART) although also observed among men with 
high HIV-1 RNA levels and not receiving HAART. Among MSM in 
HIV-discordant partnerships97,98 using condoms can signify lack of 
closeness and trust. 
RECREATIONAL DRUG USE 
Rates of drug usage such as cigarette smoking , alcohol, substance 
abuse are higher in MSM when compared to the normal general 
population. This makes a potential impacts on HIV infected MSMs:  
a) This kind of lifestyle behavior is associated with other risky 
behavior, eg. Increase in partner change and  failure of condom usage, 
b) increase chance of cardiovascular disease and malignancies which are 
associated with smoking are compounde by HIV infection. C) Illicit 
drug use for eg. Crack , cocaine , crystal, and methamphetamine, may 
exaggerate the rate of unsafe sexual practices27. D) injecting the d rugs 
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in unsafe manner increase the risk HIV transmission and hepatitis. Co -
infection with hepatitis causes rapid progression of the disease. There 
are also chances of getting infected with another strains of HIV which 
will cause additional problems , specially in pertaining to acquiring a 
resistant virus. E) this kind of lifestyle will lead on to problems with 
adherence to antiretroviral therapy ( ART) and other therapies. F) 
certain recreational drugs may cause adverse consequences due to 
metabolism of prescribed drugs. G) drugs which are used for erectile 
dysfunction or to enhance sexual performance such as sildenafil etc may 
cause drug interactions with prescribed therapies along with increased 
transmission of HIV and other STIs. 
There is relationship between alcohol and sex among MSM. 
Alcohol use may serve a unique function in the lives of MSM. Alcohol 
use among gay and bisexual men can be a reaction to social 
marginalization (e.g. homophobia, discrimination, violence) resulting 
from their sexual orientation and may be associated with other mental 
health issues such as depression, anxiety, and substance use disorders
21
. 
Harawa et al
22
 conducted a qualitative study exploring the ways in 
which non-gay identified  MSM understood the role of drugs and 
alcohol in sex with men. Four domains were identified that described the 
role of substance use in sexual encounters: substances as 1) motivators; 
2) allowers; 3) rationalizers; and 4) facilitators. While alcohol may be 
used to deal with men's discomfort regarding their sexual desires, there 
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are men for whom alcohol is intentionally used to enhance their sexual 
experiences and to gain a sense of power during the sexual experience
23
. 
A study of substance use among HIV-positive MSM found that nearly 
all (90%) of the men used drugs to enhance sexual pleasure, and that 
drug use dulled negative feelings about living with HIV
24
. Examining 
the relationship between alcohol and sexual behavior among MSM 
allows for a more understanding of the ways in which, alcohol may be 
related to condom use in this group. 
SEXUALLY TRANSMITTED INFECTIONS(STIS) 
Sexually transmitted diseases (STDs) are diseases that are 
transmitted by sexual intercourse. The older terminology of "venereal 
diseases" (VDs) largely has been replaced by ―sexually transmitted 
diseases (STDs)‖ and more recently by "sexually transmitted 
infections"(STIs). STIs differs from STDs in that STDs conventionally 
includes infections resulting in clinical diseases that may involve the 
genitalia and other parts of the body part icipating in sexual interaction 
e.g., syphilis, gonorrhea, chancroid, donovanosis, nongonococcal 
urethritis, genital warts, herpes genitalis etc. STIs, in addition, includes 
infections that may not cause clinical disease of genitals, but are 
transmitted by sexual interaction e.g., all STD‘s and hepatitis B, human 
immunodeficiency virus (HIV), HTLV-1etc. Nowadays, the term STI is 
preferred , since it covers all the diseases that can be transmitted by 
sexual intercourse. Sexually transmitted infections (STIs)  are more 
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dynamic than other infections prevailing in the community. MSM are at 
increased risk for STDs, including emergence of antimicrobial resistance 
when compared to women and exclusively heterosexual men.  
Population level factors such as limited or overlapping social and 
sexual networks further increase risk of STIs including HIV among 
MSM. In many cases, concomitant psychosocial health concerns, such as 
depression, getting easy money for a pleasurable work, illiteracy and 
unawareness of severity of STIs may predispose MSM to increased risk 
taking. Miscommunication and misperceptions about HIV serostatus and 
the presence of STDs may enable some MSM to feel comfortable 
engaging in unprotected sex16. 
The pattern of STIs are different in MSMs than normal 
heterosexuals. Among heterosexuals the bacterial STIs like syphilis, 
gonococcal infection etc is declining and the viral STIs like herpes 
genitalis and condyloma acuminate are showing upward trend. But 
among MSMs syphilis is found more common than among the 
heterosexuals which is followed by condyloma acuminate and herpes 
genitalis . Gonococcal infection comes later in the list of trend in the 
pattern of STIs. 
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REASONS FOR HIGH PREVALENCE OF STIS IN MEN WHO 
HAVE SEX WITH MEN 
BIOLOGICAL 
1) Semen higher conc of HIV [ bodily secretion ], more trauma to 
anal mucosa 
2) Penis is penetrative organ 
3) Penis is designed to transmit semen (along with anything else in 
seminal fluid) 
4) Highly receptive columnar epithelial surfaces are involved in 
male to male sex: 
 -Rectal mucosa 
 Anorectal squamo-columnar junction 
 Oropharyngeal and tonsillar mucosa 
 Urethral meatal mucosa  
 Inner surface of prepuce  
SOCIOLOGICAL 
1) Myths and ignorance abound about male to male sex-e.g., in 
countries where HIV transmission is predominantly heterosexual, 
many men believe sex with men is safer.  
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2) Barrier protection is not needed to prevent reproduction, so 
condom use is rare. 
3) Illegality discourages open expression of male to male love or 
sexual behavior. 
4) Societal stigmatization directly discourages regular open 
relationship between two males. 
5) Societal stigmatization thus indirectly encourages multiple casual 
partners. 
6) Male to male sexual activities are often covert:  
 Fleeting opportunistic contacts 
 Frequently contacts are anonymous 
 Frequent concurrent disinhibiting substance use (especially 
alcohol) 
 Sex may be in dimly lit places, so partners not clearly seen; 
protection difficult. 
 Opportunistic male to male sex work common in homophobic 
societies. 
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 MEDICAL REASONS FOR POOR CONTROL OF STIS (& 
HIV) IN MSM 
PATIENT -  CENTERED 
 Shame and guilt 
 Lack of self – esteem 
 Fear of clinician‘s disapproval  
 Decreased health seeking behavior 
 Giving an untrue sexual history if symptomatic  
CLINICIAN – CENTERED 
 Discomfort with homosexuality 
 Ambivalent feelings about MSM 
 Judgmental or moralistic 
 Irrational fear of contamination from MSM 
 Not swabbing the correct anatomical sites  
 Ignorance about testing and management of STIs in MSM 
HIV & MSM  
India has a signiﬁcant human immunodeﬁciency infection (HIV) 
epidemic. The World Health Organization (2007) estimates that there 
are about 2.5million people  currently living with HIV in the country, 
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the primary route of transmission being sexual transmission. The NACO 
prevention programs initially targeted to speciﬁc risk groups such as 
female sex workers, migrants, truck drivers, sexually transmitted 
infection (STI) patients, blood donors, and injection drug users. There 
was little discussion of the role of male-to-male sex in HIV 
transmission; consequently, there were hardly any prevention programs 
targeted toward this risk group. There is little acknowledgement of men 
whose primary sexual orientation is towards other men in India. This 
social denial percolates in the health system  as well, and thus there is 
little emphasis to elicit same-sex history in patients presenting to HIV or 
STI clinics; this resulted in paucity of research in this population. 
However, recently, there has been an increased recognition of male -to-
male transmission of HIV in the country. In response, NACO has 
initiated behavioral and sentinel HIV surveillance in men who have sex 
with men (MSM) across various cities in India (NACO, 2008b). The 
HIV/AIDS epidemic in India can be described in three coexisting 
phases: (a) the ﬁrst phase of spread of HIV among the classically 
recognized high-risk groups; (b) the second phase of spread of HIV to 
the non-high-risk groups, such as the spouses and children of infected 
individuals; and (3) the third phase of increased incidence of medical 
and social complications among those infected. In India, MSM are a part 
of the high-risk group or the ﬁrst phase, the prevalence being of the 
order of more than 10% in a few surveillance sites in the past 5 years 
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(NACO, 2008a). MSM in India are often married because of existing 
social norms  thus they also form a part of the second phase of HIV 
epidemic—they represent a ‗bridge population‘ between high-risk MSM 
networks to the nonhigh-risk group of often monogamous women. 
Further , the tag of sexual minority adds a dimension of stigma in HIV 
infected MSM, compromising their health further, and thus fueling the 
third phase of the HIV epidemic .  
PREVALENCE OF HIV AMONG MSM 
HIV infection among MSMs has been increasing in recent years 
around the world , particularly in Asia
25
, the percentage of MSM  
infected with HIV is 10% to 42%
26
. This global trend is being seen in 
India, with the current estimated HIV prevalence among MSM ranging 
between 7% to 16.5%
27-29
. This is in comparison with the overall adult 
HIV prevalence estimated to be 0.31% (0.25%-0.39%) in 2009
27
. The 
estimates for the prevalence of HIV in MSM in India vary. Pockets of 
high HIV prevalence among MSM are identified in high prevalence 
States as well as in Delhi, Gujarat and West Bengal. Twenty eight 
districts have 5 per cent or more HIV prevalence among MSM according 
to the BSS 2009
30
.  The States that have the highest mean HIV 
prevalence amongst MSM in 2008 are Karnataka, Andhra Pradesh, 
Manipur, Maharashtra, Delhi, Gujarat, Goa, Orissa, Tamil Nadu and 
West Benga
31
. While overall HIV trends amongst this population group 
are stable in India; there is an increasing trend among south Indian 
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States and Delhi. The Government of India‘s National AIDS Control 
Organization (NACO) estimates an overall HIV prevalence of 6.41 per 
cent among MSM, although this may be a lower-limit estimate
32
. For 
example, in Mumbai, 12 per cent of MSM seeking voluntary counselling 
and testing services were HIV-infected, and 18 per cent of the MSM 
screened in 10 clinics in Andhra Pradesh were found to be 
infected
25,33,34
. We found an 8 per cent prevalence in a sample of 210 
MSM in Chennai recruited by peer outreach workers
35
. In the context of 
this disproportionally high level of HIV risk, i t becomes extremely 
important to understand the socio-cultural factors that may exacerbate 
sexual risk among this group. 
MSWs are at higher risk of acquiring HIV because of following reason: 
 High number male sex partners 
 High substance abuse 
 Receptive anal sex 
 Lack of condom usage 
 High previous history of infections in deprived populations  
 Inadequate treatment of those who are having Hiv infection 
already. 
 Lower proportion of accessing to public health services  
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     SEXUAL PRACTICES AND STI/HIV TRANSMISSION          
MSM may engage in sexual practices that put them at risk for 
specific STIs, particularly HIV. Unprotected anal intercourse has been 
generally shown to be most efficient for sexual HIV transmission with 
an 8.2/1000 contact risk for unprotected receptive anal intercourse with 
a known HIV-infected partner, and 0.6/1000 contact risk for unprotected 
insertive anal sex with a known HIV-infected partner
36
. The relative 
risks of HIV transmission with partners whose status is unknown will 
reflect the background HIV prevalence in specific communities and 
culture. 
The relative efficiency of fellatio in transmitting HIV is unclear 
(because of the preponderance of at-risk men also engaging in anal 
intercourse). Among MSM followed in the Multicenter AIDS Cohort 
Study, men who only engaged in receptive oral intercourse and no anal 
intercourse were identified among the seroconverters
37
. Vittinghoff 
36
 
and colleagues estimated the per contact risk of unprotected oral 
exposure to the ejaculate of HIV-infected or status unknown partners to 
be 0.4/1000, which was comparable to their estimate of the risk from 
unprotected insertive anal sex. 
Despite the effects of HAART in lowering HIV concentrations in 
different compartments, HIV RNA has been detected in the semen
38
, 
rectal secretions
39
, and pharyngeal samples
39
 of MSM on suppressive 
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antiretroviral therapy
40
. Reports of increase in sexually transmitted, 
drug-resistant HIV also suggest that HAART alone will not necessarily 
prevent new infections from occurring in MSM. Other cofactors 
associated with increased HIV transmission among MSM include the use 
of volatile inhaled nitrates and being uncircumcised. Other STDs are 
also efficiently transmitted by anal intercourse, including syphilis, 
gonorrhea, chlamydia infection, herpes simplex virus, and hepatitis B. 
Many of these pathogens may also be more efficiently transmitted 
through fellatio than HIV. Human papillomavirus (HPV) is readily 
transmitted without anal penetration, and may be autoinoculated from 
the penis to the rectum in sexually active MSM. Other nontraditional 
STDs may be readily transmitted by specific MSM practices, e.g., 
enteropathogens like Shigella or Salmonella may be spread by oral–anal 
intercourse (―rimming‖) or digital–anal contact (―fisting‖) because of 
the low pathogen inoculum needed to cause infection.  
SYPHILIS  
Although national syphilis elimination efforts have proven very 
successful in many communities in recent years
41
, reports of increasing 
rates of new infections among MSM continue to occur
42
, with 
disproportionate numbers of newly diagnosed syphilis patients being 
HIV coinfected
43
. Almost one-quarter (23%) of HIV-infected MSM 
accessing services at an STD clinic participating in the U.S. Gonorrhea 
Isolate Surveillance Program (GISP) had a reactive syphilis serology 
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compared to 8% of MSM who were HIV uninfected or whose serostatus 
was unknown
44
. Overall, seroreactivity ranged from 4% to 11% by clinic 
location. The male-to-female primary and secondary syphilis rate ratio 
increased from 1.2 in 1996 to 5.7 in 2005, primarily due to the 
resurgence of syphilis among MSM.55 Futhermore,CDC data reveal 
almost a tripling in median syphilis seropositivity from 4% in 1999 to 
11% in 2005 among MSM visiting the STD clinics participating in the 
national MSM prevalence monitoring project.55 . The increased 
prevalence ofsyphilis in HIVcoinfected MSM may also reflect 
―serosorting,‖ i.e., careful selection by HIV-infected MSM of other 
infected partners with whom they can have unprotected sex and/or 
increased susceptibility to syphilis among HIV-infected patients. Since 
oro-pharyngeal chancres may transmit infectious syphilis to insertive 
partners engaging in oral sex,this practice that is considered safe in 
relation to HIV transmission may result in new syphilis infections,and 
safer sex education should take this risk when prevention messages are 
developed for MSM. 
GONORRHEA 
Gonorrhea rates have also increased in recent years among urban 
MSM in developed countries, paralleling the rises seen with syphilis
45,46
. 
Gonorrhea may be transmitted by fellatio,as well as insertive or 
receptive anal intercourse, although anal sex is the most efficient means 
of transmission. According to the GISP, the proportion of positive test 
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results for MSM increased from 4% in 1988 to more than 20% in 2005. 
The median clinic test positivity rate was 11% for urethral gonorrhea,8% 
for rectal gonorrhea,and 7% for pharyngeal gonorrhea . Quinolone -
resistant gonococci have been increasingly isolated from MSM, 
constituting 29% of specimens from MSM in CDC‘s GISP in 2005 and 
necessitating the use of expanded spectrum cephalosporins for the 
treatment of gonococcal infections in MSM, and the recommendation 
that quinolones no longer be used to treat any gonococcal infection in 
MSM. 
HERPES SIMPLEX VIRUS TYPE 2 
Herpes simplex virus type 2 (HSV-2) is extremely prevalent in the 
general population worldwide
47-49
, with more than one fifth of the U.S. 
population being infected with HSV-2
50,51
. The prevalence is much 
greater in sexually active MSM, with more than half  of any survey of 
MSM demonstrating seroreactivity. HIV has been readily detected by 
PCR from HSV-related male genital ulcers of 70% of a certified cohort 
in one series
52
, consistent with data supporting its role in potentiating 
HIV transmission. Large public health trials are underway to assess 
whether the ongoing use of acyclovir—an HSV-2 thymidine kinase 
inhibitor—can protect HSV-2-infected, HIV uninfected high-risk 
individuals from HIV acquisition, or decrease the likelihood of HIV 
transmission by HIV-1/HSV-2 coinfected individuals. 
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HUMAN PAPILLOMAVIRUS (HPV): 
It is thought to be the most common STD in the United States and 
other developed countries
53
, with more than 85% of HIV-infected MSM 
being HPV coinfected
54-56
 and the prevalence of HPV in HIV-uninfected 
MSM being consistently greater than 50%.HPV is primarily spread 
between male sexual partners through insertive or receptive anal 
intercourse, but may also be transmitted by oral sex,108 digital–rectal 
contact and scrotal contact. Reports of anal cancer in HPV-infected 
MSM have led to suggestions that routine anal screening for atypia and 
proactive management of precancerous lesions should be part of the 
primary care of MSM engaging in anal intercourse.  
CDC RECOMMENDATIONS FOR STD SCREENING FOR 
MEN WHO HAVE SEX WITH MEN: 
Annual screening of sexually active MSM for:  
 HIV serology, if HIV seronegative or not tested within the 
previous year 
 Syphilis serology 
 A test for urethral infection with N. gonorrhoeae and C. 
trachomatis in men who have engaged in insertive intercoursea 
during the preceding year 
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 A test for rectal infection  with N. gonorrhoeae and C. trachomatis 
in men who have had receptive anal intercourse a during the 
preceding year 
 A test for pharyngeal infection with N. gonorrhoeae and C. 
trachomatis in men who have acknowledged participation in 
receptive oral intercoursec during the preceding year; testing for 
C. trachomatis pharyngeal infection is not recommended.  
 Some specialists would consider type-specific serologic tests for 
HSV-2, if infection status is unknown. 
 Routine testing for anal cytologic abnormalities or anal HPV 
infection is not recommended until more data are available on the 
reliability of screening methods, the safety of and response to 
treatment, and programmatic considerations 
 More frequent STD screening (i.e., at 3–6months intervals) is 
indicated for MSM who have multiple or anonymous partners, 
have sex in conjunction with nonprescription or nonmedically 
indicated drug use, or whose sex partners participate in these 
activities 
PUBLIC HEALTH PRACTICE AND MSM 
Several investigators have called attention to the need for 
structural and environmental interventions to promote safer sexual 
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practices among MSM
57,58
 . There are no definitive public health data 
that demonstrate that specific local structural interventions which led to 
reductions in rates of STDs. However, it may be argued that 
criminalization of homosexual behavior has never eradicated the desire 
to engage in specific practices. Punitive legal constraints and 
homophobic social environments could serve to drive such activity 
underground, making it harder for public health officials to identify 
sexual contacts. The governments of several European countries, 
Canada, and Australia have been able to work with the gay community 
to create culturally sensitive legal and public-health environments, 
allowing for the effective detection and treatment of STDs and HIV 
infection; however, none has seen a diminution in the recent increases in 
new infections among MSM.  
GAY BOWEL SYNDROME 
Gay bowel syndrome was a medical term first used by Henry L 
Kazal and colleagues to describe the various sexually transmitted 
perianal and rectal diseases and sexual traumas seen in Kazal's 
proctology practice, which had many gay patients. The term was first 
used in the pre-HIV era, by Kazal et al. in 1976. The term was not 
specific to any particular disease or infection, and was used clinically to 
describe proctitis and a variety of other complaints caused by a wide 
range of infectious organisms. Reported causes include herpes viruses, 
syphilis, gonorrhea, chlamydia, campylobacter, and shigellosis, as well 
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as a variety of protozoal infections. The concept of "gay bowel 
syndrome" was later expanded to include various opportunistic cancers. 
Transmission of disease was considered to take place by two routes: anal 
sex, and fecal-oral route. Sometimes, difficulty in specifying the method 
may be a result of transmission by both methods.  
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METHODS AND MATERIALS 
SOURCE OF DATA 
MSM attending sexually transmitted disease OPD 
PLACE OF STUDY 
Govt. Stanley Medical College, Chennai 
TYPE OF STUDY 
Cross Sectional Observational  Study 
TIME OF DURATION 
1 year (August 2016 – August 2017) 
SAMPLE SIZE 
100 
INCLUSION CRITERIA 
 Men having sex with men of: 
 >18 years of age 
 Anoinsertive & receptive 
 Oroinsertive & receptive 
 >1partner 
 Transgenders(TGs) 
 Bisexuals 
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EXCLUSION CRITERIA 
 Single male partner 
 Last contact >10 years 
PROCEDURE 
After elaborate history taking and clinical examination of each 
individual, written and informed consent, under aseptic precautions 
peripheral blood was taken and sent for :  
 HIV 1 and 2(HIV1+2 immunodot test kit , ½ trispot kit ,SD 
BIOLINE) 
 RAPID PLASMA REAGIN test (SPAN) 
 TPHA (if RPR is positive) 
 Hepatitis B surface antigen (HBsAg) 
 Hepatitis C antibodies (Anti HCV) 
 IgG Antibodies against HSV 1 and 2 (Calbiotech ELISA)  
 Additional investigations, such as dark ground microscopy, 
Tzanck smear, gram staining leishaman staining, and KOH 
smears, biopsy were carried out wherever required.  
I KIT 
HIV 1 + 2 IMMUNODOT TEST KIT ( COMBAIDS): 
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Dot immunoassay for the detection of antibody to HIV 1 and / or 2  
PRINCIPLE 
Dot immunoassay employs the same principle as Enzyme 
Immunoassay (EIA) whereby the immobilized antigen- antibody 
complex is visualized by the means of colour  producing ( chromogenic) 
reaction. In EIA the colour is developed by a coupled reaction between 
enzymes, substrate and chromogen where as in Combaids – HIV 1 + 2 
immunodot test kit the coloured endpoint is developed by a Colloidal 
Gold- Protein – A  
Signal Reagent4,5. Each tooth of the Comb is spotted with a 
circular spot , one near the tip with an optimally standardized blend of 
HIV 1 and HIV 2 recombinant antigens and / or synthetic peptides (Test 
spot), and the other spot, a little above the first spot is spot ted with 
―Control Reagent‖ (Control spot). When incubated with a specimen 
containing HIV 1 and /or 2 antibodies, these antibodies bind directly to 
the HIv antigens present in the ―Test Area‖ on the tooth of the comb. 
The immune complex is directly visualized after incubation with 
Colloidal Gold- Protein - A – Signal Reagent. A positive result is 
indicated by the presence of pink coloured spot / dot in the ―Test 
area‖near the tip of the tooth of the comb where antigens are spotted. 
Built in control is visualised separately in the upper part of the tooth 
(Control Area), where control reagent  has been spotted, serving as the 
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procedural control. A pink color spot or dot will always appear at  
―Control Area‖ during the test after application of the test sample 
detecting presence of human immunoglobulins( IgG), irrespective of the 
presence or absence of HIV specific antibodies in the specimen.  
SAMPLE  
Whole blood, Serum or Plasma can be used.  
(Whole blood should always be used freshly collected in EDTA/ 
Heparin / citrate anticoagulant) 
REAGENTS 
Reagent 1: washing buffer 
Reagent 2 : signal reagent 
Reagent 3 : sample diluent 
Reagent 4 : negative control 
Reagent 5 : positive control 
Reagent 6 : antigen and control reagent coated combs 
SETTING UP THE TEST 
Washing solution: Dilute (reagent 1) the concentrated washing 
buffer to 1:5 with distilled water by adding 2ml of concentrated washing 
buffer to 8ml distilled water, taking care to avoid a foaming. Fill the 
wash reservoir with washing solution. 
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ASSAY PROCEDURE 
All kit components and sample to be tested should be brought to 
room temperaturebefore starting the test. Clearly mark all sample to be 
tested and record their identity before starting the test.  
1) Mark the samples number on the microtest wells and add two 
drops of Sample diluent (reagent 3) to each microtest well that 
will be used for sample or controls.  
2) Add two drop(0.1ml) of sample to each of the above wells 
containing sample diluent. Mix the sample with diluent by 
repeated aspirating and expelling or stirring with disposable 
plastic dropper tip. Record the position and identity of samples or 
controls as they are needed.  
3) carefully remove the comb (reagent 6) from the blister pack and 
place it into rows of corresponding microtest wells.  
4) Place the comb into the first row of diluent samples by holding 
the comb vertically with the teeth pointing down. Set the timer 
for10min and the start the timer. Incubate exactly for 10 minutes 
at room temperature . 
5) In the mean time, dispense 4 drops (0.2ml) of signal reagent 
(reagent 2) into each of the another set of unused microtest wells.  
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6) Remove the comb from the sample containing wells and blot the 
tips of the teeth on absorbent material. We should not blot the 
reactive surface of the comb. Hold the comb vertically with tips 
pointing down and rock them forward and backward in the wash 
solution for a total of ten minutes. Blot the tips of the arms again.  
7) Place the comb into the well containing signal reagent (reagent 2). 
Incubate exactly for 10 minutes at room temperature. After 
incubation, repeat thewashing procedure as described in step 6.  
8) Place the comb on a clean surface, reactive side up. Do not blot or 
wipe the surface of the comb. Allow the comb to air dry 
completely before reading the results. 9) use the reference color 
index for SPIA to compare and interpret the results.  
 INTERPRETATION 
The surface of the comb should be perpendicular to the eyes and 
should be viewed at 90 degree angle to avoid viewing as a faint , 
uncolored spot / dot which does not  represent the true reactivity. 
REACTIVE  
 Appearance of pink colored dot or spot on both ―test area‖ and 
―control area‖ indicate positive results as shown in picture.  
 The positive results on test spot/ dot shows either HIV 1or HIV 2 
or both together. 
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 However , intensity of spot / dot shall be equal to more than 1.0 
color index when compared with references color index for SPIA.  
NON REACTIVE  
Absence of pink spot/ dot in a test area indicate negative result as 
shown in the  picture. However in such case pink spot / dot shall be 
present in ―control area‖. 
 INDETERMINATE RESULT 
The test should be considered as ―indeterminate‖ in case of faint 
colored spot / dot in test area having color intensity between 0.00 and 
1.0 color index. In such cases it is recommended to repeat the test to 
confirm the results, if the results is still ―indeterminant‖, fresh sample 
should be drawn often after 4-8 weeks and retested again. 
INVALID RESULTS 
The test is to be considered as ―invalid‖ if no pink coloured spot / 
dot is visible in ―control area‖ irrespective of presence or absence of 
pink colored spot / dot in the test area. In such cases the test should be 
repeated using a new comb and fresh specimen.  
II  KIT: 
HIV – 1/2 TRISPOT TEST KIT  
(A RAPID TRISPOT TEST TO DETECT ANTIBIOTICS TO HIV 
1 & 2 IN HUMAN SERUM & PLASMA) 
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HIV – 1/2 TRISPOT is an immune concentration based assay for 
detection of antibiotics to HIV 1 & 2 in human serum & plasma.  
INTRODUCTION 
It is an immunoassay which employs r- protein for the detection 
of antibodies to HIV in human serum and plasma. These proteins, which 
are corresponding to highly antigenic segments of both the structural 
and non-structural proteins of the HIV constitute the solid phase of 
antigenic absorbent. The use of r-proteins offers the advantage of high 
degree of specificity and sensitivity due to multiple epitopes. 
Serological cross reactitivity between HIV-1 and HIV-2 has been shown 
to be highly variable from sample to sample. This variability 
necessitates the inclusion of antigens to both HIV-1 and HIV-2 for the 
detection of HIV-1 and HIV-2. The HIV genome has outer structural 
(env-gp120, gp41), inner structural (gag p17, p24, p7, p6), pol -viral 
enzymes (protease, reverse transcriptase, integrase) and regulatory 
proteins (Tat, Rev, Vif, Vpu, Vpr, Nef) and long terminal repeats on 
either end (fig 1) 
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It utilizes a unique combination of HIV1 & 2 antigens of the virus 
to selectively detect all subtypes of HIV-1 & 2 Virus in human 
serum/plasma with a high degree of sensitivity and specificity. The level 
of different type of antibodies and antigens of HIV in blood is as shown 
in (Fig. 2) 
 
TEST PRINCIPLE 
HIV-1 & HIV-2 antigens (HIV-1 & HIV-2) and a Control antigen 
( C ) are immobilized on a porous immuno filtration membrane. Sample 
and the reagent pass through the membrane and are absorbed into the 
underlying absorbent pad. As the patient‘s sample drains through the 
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membrane, HIV antibodies if present in serum / plasma, bind to the 
corresponding immobilized antigens. Unbound serum / plasma proteins 
are washed off in the subsequent washing step. Addition of the protein-
A conjugate results in binding of HIV to give distinct Red Spot near the 
test region (HIV-1 & HIV-2). At the control region (‖C‖) a ―Built in-
Quality Control Spot‖ has been coated to confirm the proper functioning 
of the device, reagent and correct procedural application.  
KIT CONTENT 
 Test device 
 Buffer soliution 
 Gold conjugate 
 Droppers 
 HIV 1 & 2 positive control 
 HIV 1 & 2 negative control 
SPECIMEN PROCESSING 
HIV-1/2 TRISPOT Test works best when used with fresh samples, 
however the frozen or viscous samples can also perform well if the 
following instructions are strictly adhered to A. Frozen samples : (I) 
Allow the sample to thaw in a vertical position in the rack. Mix the 
sample thoroughly. If particles are seen, allow them to settle at the 
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bottom or if a centrifuge is available, the sample can be centrifuged at 
5,000 r.p.m. for 15 minutes. (ii) Insert the dropper just below the top 
surface of the sample and withdraw two drops of the sample. B. Thick or 
viscous samples : Whenever possible, clear specimen should be 
used.However, viscous, thick or turbid samples which may sometimes 
take more than 40- 60 seconds to flow through the membrane should be 
centrifuged at 5,000 r.p.m. for 15 minutes and retested on a fresh  device 
to avoid inconsistent results. 
TEST PROCEDURE 
1) Bring all the reagents. devices and specimens to room temperature 
(25+5°C). 
2) Add 2 drops of buffer solution to the test device.  
3) Add 2 drops of either serum or plasma. 
4) Add 4 drops of buffer solution. 
5) Add 2 drops of gold conjugate. 
6) Add 4 drops of buffer solution. Reading of the Results should be 
done immediately. Do not read after 5 minutes.  
RESULTS 
Interpretation of Results 
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1. NEGATIVE: If only one red spot (control spot) appears at the 
control region "C" indicates that the specimen does not contain 
antibodies either to HIV-1 or HIV-2. (Fig. 3) 2. POSITIVE: (a) If two 
red spots (Control spot and HIV-1 or HIV-2 Spot) appear at the control 
region "C‖ and test region HIV-1 and/or HIV-2 indicates that the 
specimen is reactive for antibodies to HIV-1 and/or HIV2. (Fig. 4) (b) If 
three red spots (Control. HIV-1 & HIV-2 Spot) appear at the control 
region "C" and test region HIV-1 & HIV-2 indicates that the specimen is 
reactive for antibodies to HIV-1 & HIV-2.(Fig .5). 3) INVALID 
RESULT: If no spot appears after the completion of test. either with 
Clear background or with complete reddish background the test 
indicates ERROR. (Fig. d) This may indicate a procedural error or 
deterioration of specimen / reagents or part iculate matter in the 
specimen. The specimen should be retested on a fresh device.  
   
Fig-3 Fig-4 Fig-5 
3RD KIT 
THE 3RD GENERATION OF ONE STEP ANTI HIV 1 / HIV 2 
TEST 
EXPLANATION OF THE TEST 
It is an immunochromatographic ( rapid test), qualitative te st for 
the detection of antibodies to all isotypes (IgG, IgM, IgA) specific to 
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HIV-1 including subtype-O and HIV-2 simultaneously in human serum, 
plasma or whole blood. The SD BIOLINE HIV 1/2 3.0 test contains a 
membrane strip, which is precoated with recombinant HIV-1 capture 
antigen (gp41, p24) on test line 1 region and with recombinant HIV-2 
capture antigen (gp36) on test line 2 region respectively. The 
recombinant HIV-1/2 antigen (gp41, p24 and gp36)-colloid gold 
conjugate and the sample move along the membrane 
chromatographically to the test region (T) and forms a visible line as the 
antigen-antibody gold particle complex forms with high degree of 
sensitivity and specificity . The Test line and control line in the result 
window have been clearly label : ―1‖ for test line 1 and ―2‖ for test line 
2 and ―C‖ for Control line. Both test line and control lines in the result 
window are not visible before applying any sample. The Control line is 
used for procedural control and should always appear if the test 
procedure is performed correctly. It is a rapid, qualitative test for the 
detection of antibodies to all isotypes(IgG, IgM, IgA) specific to HIV-1 
and HIV-2 simultaneously in human serum, plasma or whole blood.  
Materials Provided / Active ingredients of main components  
1) The kit contains the following items to perform the assay.  
 Test devices individually foil pouched with a desiccant  
 Assay diluents  
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 20µl capillary pipettes(Option), Lancets (Option)  
2) Active ingredients of main components 
 1 test strip included ; Gold conjugate (as main component) : 
Recombinant HIV-1 gp41, p24, HIV-2 gp36 antigen – gold 
colloid(1±0.2µg), Test line 1 (as main component) : 
Recombinant HIV -1 antigen (gp41, p24) (0.625±0.125µg), 
Test line 2 (as main component) : Recombinant HIV -2 antigen 
(gp36) (0.5±0.1µg), Control line : Goat anti-HIV serum 
(0.75±0.15µg)  
 Assay diluents : 50mM Tris-HCl Buffer, Sodium 
azide(0.02w/v%) 
Specimen collection, storage and precaution  
Whole blood [Collection by venipuncture or using lancet]  
INTERPRETATION OF THE TEST  
1) A color band will appear in the left section of the result window 
to show that the test is working properly. This band is control line 
(C). 
2) Color bands will appear in the middle and right section of the 
result window. These bands are test line 2 and test line 1 (2, 1). 
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NEGATIVE RESULT 
The presence of only control line (C) within the result window 
indicates a negative result. 
POSITIVE RESULT  
The presence of two lines as control line (C) and test line 1 (1) 
within the result window indicates a positive result for HIV-1. (FIG-6). 
 
 The presence of two lines as control line (C) and test line 2 (2) 
within the result window indicates a positive result for HIV-2. 
 The presence of three lines as control line (C), test line 1 (1) and 
test line 2 (2) within the result window indicates a positive result 
for HIV-1 and/or HIV-2.  
o If the color intensity of the test line 1 is darker than one of test 
line 2 in the result window, you can interpret the result as 
HIV-1 positive. 
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o If the color intensity of the test line 2 is darker than one of test 
line 1 in the result window, you can interpret the result as 
HIV-2 positive.  
Caution: Although a positive result for HIV-1 and HIV-2 in one 
patient is a rare case, it's possible as there is an homology in the amino 
acid sequence between HIV-1 and HIV-2. To determine the virus type or 
diagnose a co infection accurately, you must perform a supplementary 
test as Western Blot etc. 
 INVALID RESULT  
No presence of control line (C) within the result window indicates 
an invalid result. The directions may not have been followed correctly 
or the test may have deteriorated. It is recommended that the specimen 
be retested. 
RPR (RAPID PLASMA REAGIN) KIT – SPAN 
(FLOCCULATION TEST) 
PRINCIPLE : 
RPR test is a modified version of Wassermann's reaction in  
which the antigens coated  with  carbon particle  are allowed to react 
with the  sample  and if the antibodies  for syphilis are present the 
flocculation will occur on the card due to aggression of carbon particle. 
If the sample does not contain the antibody then there will not be any 
flocculation and it will give clear back ground.  
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CLINICAL SIGNIFICANCE  
Syphilis   is   caused    by   the   organism  Treponema palladium 
palladium .  
SAMPLE  
Fresh serum or plasma separated by using EDTA, heparin or 
oxalate as anticoagulant is preferred. Venostasis to be avoided.  
PROCEDURE  
Rapid plasma regain test are performed on unheated serum or 
plasma with modified antigen suspension with addition of:  
Choline chloride, EDTA .charcoal.  
QUALITATIVE TEST: 
 Place 0.05ml unheated serum onto a 18mm circle of test card .  
 Spread serum with stirrer to fill entire circle.  
 Add 1 drop (1/60ml) RPR card antigen to each test area 
containing serum. 
 Do not stir. 
 Place the card on rotator with humidifier cover.  
 Rotate 8 min at 100rpm. 
 Read test without magnification immediately after rotation.  
 Read the results as follows. 
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INTERPRETATION OF RESULT 
Definitive clumps: Reactive (R) 
No clumps: Non-reactive (NR) 
QUANTITATIVE TEST 
Do same as above with doubling dilution of serum with 0.9% 
saline like 1:1, 1:2, 1:4 etc. 
LIMITATIONS  
The  cardiolipin  antigens  used   in  RPR   test  may  tend to  give 
Biological  false Positive  (BFP) reaction  in the conditions  like malaria,   
lepromatous    leprosy,   collagen disease,   rheumatoid arthritis,  
Infectious   mononucleosis, rubella,  mumps,  measles leptospirosis, 
relapsing fever, ratbite fever etc. In such a condition a positive reaction 
should  be confirmed  by  other  treponemal tests  like TPHA (Treponema 
pallidum heamagglutination test), TPI (Treponema pallidium  
immobilisation),  FTA (fluorescent Treponemal Antibody)  test .  
 
1:4 dilution reactivity (FIG-7) 
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TPHA KIT  
(TREPONEMA PALLIDUM HEAMAGGLUTINATION TEST) 
Treponema pallidum Hemagglutination Assay (TPHA) is a 
specific treponemal test for the serologic diagnosis of syphilis, a 
sexually transmitted infection caused by a Spirochetes, Treponema 
pallidum.  Based on the principle of passive haemagglutination, this test 
detects anti-treponemal antibodies (IgG and IgM antibodies) in serum or 
CSF.  TPHA is a good primary screening test for syphilis at all stages 
beyond the early primary stage. 
PRINCIPLE 
The test sample is diluted in absorbing diluent to remove possible 
cross-reacting heterophile antibody and to remove, block, or absorb 
potentially cross-reacting, nonpathogenic treponemal antibodies. Sera 
containing antibodies to T. pallidum react with  erythrocytes (chicken or 
avian) sensitized with sonicated T. pallidum, Nichols strain (the 
antigen), to form a smooth mat of agglutinated cells in the microtiter 
tray well. If antibodies are not present the cells settle to the bottom of 
the tray well, forming a compact button of unagglutinated cells.  
 REAGENT  
1) Test Cell suspensions: Preserved  RBCs treated with tannic acid 
and coated with T. pallidum antigen. 
2) Control cell suspension: Preserved RBCs (without immobilized T. 
pallidum antigen) 
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3) Buffer: Phosphate buffered saline solution containing adsorbers 
(used to remove possible cross-reacting heterophile antibodies).  
4) Positive Control serum: Human serum containing antibodies 
against T. pallidum. Ready for use. This will give an equivalent 
titer of 1/640 to 1/2560 with the quantitative test.  
5) Negative Control serum:  Human serum free of antibodies against 
T. pallidum 
PROCEDURE 
Before performing the test procedure, bring the sample, diluent, 
control and test cells in room temperature (25 – 30º C).  For each 
qualitative test, a test card with three wells is needed.  
A: Dilution of serum sample  
1) Add 10μL of patient‘s serum in the first well (say well A).  
2) Add 190 μL of diluent (provided by the manufacturer).  
3) Mix the content well using a micropipette; we will use this diluted 
serum later. 
B: Testing of serum sample for the presence of specific antibodies  
1) Add 75μL of ―control cells‖ to well B and 75 μL of ―test cells‖ to 
well C. 
2) Add 25μL of diluted serum on each B and C well.  
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3) Shake the plate gently to mix the contents thoroughly.  
4) Cover the plate and protect to direct sunlight, heat and any source 
of vibration. 
5) Incubate 45-60 minutes at room temperature. 
6) Read the test results and interpret.  
Positive control and negative control should be run along with the 
test serum 
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RESULTS AND INTERPRETATION 
Results Test cells Control cells 
Strongly Reactive Full cell pattern covering the 
bottom of the well 
No agglutination 
tight button 
Weakly Reactive Cell pattern covers approx. 
1/3 of well bottom 
No agglutination 
tight button 
Indeterminate 
(Equivocal)  
Cell pattern shows a 
distinctly open centre 
No agglutination 
tight button 
Nonreactive  Cells settled to a compact 
bottom, typically with a small 
clear center 
No agglutination 
tight button 
If the controls (positive control and negative control) do not give 
the expected result, all assays performed in that batch are  invalid and 
must be tested again. 
FALSE POSITIVE RESULTS  
Although TPHA test is highly specific, false positive results have 
been known to occur in patients suffering from leprosy, infectious 
mononucleosis and connective tissue disorders. For confirmation  FTA-
ABS test should be used. 
HBSAG AND ANTI- HCV 
Qualitative analysis is done by using ELISA method.  
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HSV (HERPES SIMPLEX VIRUS) KIT: (CALBIOTECH KIT 
FOR HSV 1 & 2 IGG ELISA) 
INTENDED USE 
The Calbiotech HSV-1 and 2 IgG ELISA Kit is intended for the 
detection of IgG antibody to HSV-1&2  in human serum or plasma.  
 SUMMARY AND EXPLANATION  
HSV-1 and 2 are virtually identical, sharing approximately 50% 
of their DNA and have over 80% of common antigens. Both types infect 
the body's mucosal surfaces, usually the mouth or genitals, and then 
establish latency in the nervous system. For both types, at least two-
thirds of infected people have no symptoms, or symptoms too mild to 
notice. However, both types can recur and spread even when no 
symptoms are present. HSV type 1 is the cause of most orofacial herpes 
and HSV encephalitis; type 2 is the primary cause of initial and 
recurrent genital herpes and neonatal HSV. Reactivation of latent HSV 
infection is a frequent complication of immunosuppression due to 
cancer, transplantation and AIDS. Asymptomatic genital shedding of 
HSV-2 is more common than HSV-1 and occurs more frequently during 
the first 3 months after acquisition of primary type 2 disease than during 
later periods. The presence of HSV IgG antibody is indicative of 
previous exposure A significant increases in HSV IgG is an indicative of 
reactivation, current or recent infection. IgM antibody is present after 
primary HSV infection.  
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PRINCIPLE OF THE TEST 
 Diluted patient serum is added to wells coated with purif ied 
antigen. IgG specific antibody, if present, binds to the antigen.  All 
unbound materials are washed away and the enzyme conjugate is added 
to bind to the antibody-antigen complex, if present.  Excess enzyme 
conjugate is washed off and substrate is added.  The plate is incubated to 
allow the hydrolysis of the substrate by the enzyme.  The intensity of the 
color generated is proportional to the amount of IgG specific antibody in 
the sample. 
REAGENT PREPARATION 
Prepare 1X Wash buffer by adding the contents of the bottle (25 
ml, 20X) to 475 ml of distilled or deionized water. Store at room 
temperature (18-26 °C). 
PROCEDURE 
Bring all specimens and kit reagents to room temp (20-25 °C) and 
gently mix.   
1. Place the desired number of coated strips into the holder.   
2. Negative control, positive control, and calibrator are ready to use. 
Prepare 1:21 dilution of test samples, by adding 10 µl of the sample 
to 200 µl of sample diluent.  Mix well.  
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3. Dispense 100 µl of diluted sera, calibrator and controls into the 
appropriate wells.  For the reagent blank, dispense 100µl sample 
diluent in 1A well position.  Tap the holder to remove air bubbles 
from the liquid and mix well.  Incubate for 20 minutes at room 
temperature.  
4. Remove liquid from all wells. Wash wells three times with 300 µl of 
1X wash buffer.  Blot on absorbance paper or paper towel.  
5. Dispense 100 µl of enzyme conjugate to each well and incubate for 
20 minutes at room temperature.  
6. Remove enzyme conjugate from all wells. Wash wells three times 
with 300 µl of 1X wash buffer.  Blot on absorbance paper or paper 
towel.  
7. Dispense 100 µl of TMB substrate and incubate for 10 minutes at 
room temperature. 
8. Add 100 µL of stop solution.  
9. Read O.D. at 450 nm using ELISA reader within 15 min. A dual 
wavelength is recommended with reference filter to 600-650 nm. 
Cut Off Value  
Calibrator OD x Calibrator Factor (CF).  
Ab (Antibody) Index = the O.D. value of each sample by cut-off value. 
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Validity   
The O.D. of the Calibrator > 0.250.  
The Ab index for NC < 0.9 
The Ab Index for PC > 1.2 
INTERPRETATION 
The following is intended as a guide to interpretation of HSV-1 
IgG test results; each laboratory is encouraged to establish its own 
criteria for test interpretation based on sample populations encountered.  
Antibody Index Interpretation : 
 <0.9 - No detectable antibody to HSV-1 & 2 IgG by ELISA.   
 0.9-1.1 - Borderline positive.  
 >1.1 - Detectable antibody to HSV-1 & 2 IgG by ELISA. 
STATISTICAL ANALYSIS 
The collected data were analysed with IBM.SPSS statistics 
software 23.0 Version.To describe about the data descriptive statistics 
frequency analysis, percentage analysis were used. To find the 
significance in categorical data Chi-Square test and Fisher's exact test 
was used. In both the above statistical tools the probability value .05 is 
considered as significant level. 
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RESULTS 
Demographic profile 
Out of 100 MSMs, 64 patients belongs to the age group of 20-30 
years  followed by 32 patients who belongs to the age group of >30 
years. The minimum age was found to be 18 years and the maximum age 
found was 46 years. TABLE 1. 
Age Number 
< 20 years 4 
20-30 years 64 
>30years  32 
Total 100 
Of total, 9 patients were illiterate, 10 patients had completed 
primary school education, 63 patients had completed secondary and 
higher secondary education i.e from 8
th
 -12
th
 standard, and 18 patients 
had completed degree. ( TABLE 2). 
Education status Number 
Illiterate  9 
Primary education (<8th std) 10 
8th-12th std  63 
Degree 18 
Total 100 
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Occupation among MSMs varied from:.(TABLE3).  
OCCUPATION NUMBER 
House keeping 15 
Coolie  28 
Male sex worker (MSWs) 25 
Other (carpenter, driver, caterer, educator) 32 
Total 100 
 
Regarding Marital status: .(TABLE 4). 
Marital Status Number 
Unmarried  70 
Married  30 
Total 100 
Double-decker (49) was the commonest sub-typology of MSM, 
followed by Kothis (32), TGs (13) and Panthis (6) respectively.(FIG-8) 
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RISK FACTORS PROFILE 
Out of 100, 77 patients were alcoholic and 69 were smokers.12 
had history of intravenous  drug abuse and 9 had a history of 
jaundice.(FIG-9).  Blood transfusion was done in 2 patients.  
 
SEXUAL BEHAVIOR PROFILE 
Of total, 64 had history of recent exposure with in 1 month 
duration , 23 patients had within past 1-6 months of duration.  (FIG-10) 
 
 
63 
The initiation of exposure of sex is most common in  the  age 
group of 16-20 yrs (55), followed by 21-25 yrs (32). 4 patients had their 
first exposure at the < 16 yrs of age. Out of 4 ,three had a history of 
child abuse. (TABLE-5). 
Exposure since (years) Number 
<16 4 
16-20 55 
21-25 32 
26-30 4 
>30 5 
Total 100 
Regarding status of partner, 53 patients had recent exposure with 
unknown partners and 47 had with known partners. (TABLE-6) 
Status of partner Number 
Unknown 53 
Known  47 
Total 100 
Out of 100, 65 patients gave history of condom usage in the last 
contact. Among these 65 patients 48 of them had used it for anal sex.  
(TABLE-7) 
Condom usage during last contact Number 
Yes 65 
No 35 
Total 100 
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Nearly half of the patients (47%) acknowledged to having being 
paid for recent sex. 
Figure(11) shows pattern of sexual intercourse: the highest 
number of patients were anoreceptive (42%) .  
 
Of total, 13 had undergone reconstructive surgery (total 
amputation of penis and scrotum with urethral meatus reconstruction) of 
the external genitalia. (TABLE-8) 
Reconstructive surgery Number 
Yes 13 
No 87 
Total 100 
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PREVALENCE OF STIS  
Out of 100 patients (MSMs) who attended the opd, 23 cases came 
with symptoms, 11 cases for self screening and 66 cases were bought by 
various Non Governmental Organisations(NGOs) (SAHODARAN-1 & 
2, SWAM{social welfare association for men}, ICWO{indian 
community welfare organization}, ARM,TRA{Transgender 
Association}). (FIG-12) 
 
After evaluation 27 patients were newly diagnosed with sexually 
transmitted infections.(FIG-13) 
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Out of rest 73 patients, 7 cases were old case of sexually 
transmitted infection and 7 had non venereal dermatoses. Out of 100, 59 
were non diseased. 
Out of 66 without any disease and non venereal disease, 
62(94%)were given presumptive treatment. (TABLE-9) 
Presumptive treatment Number  (%) 
Yes 62 (94%) 
No 4 (6%) 
Total 66 (100%) 
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Among 27 newly diagnosed STIs , following is the pattern of 
STIs: (TABLE-10), (FIG-14) 
STIs Number (%) 
HIV 1 4 (14.8) 
Syphilis 5 (18.5) 
Wart  7 (26) 
Gonococcal urethritis 4 (14.8) 
MC(molluscum contagiosum) 2 (7.4) 
Herpes genitalis 2 (7.4) 
Hepatitis B 2 (7.4) 
Genital scabies 1 (3.7) 
Total 27 (100) 
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ASSOCIATION BETWEEN SELECTED SOCIO-
DEMOGRAPHIC FACTORS AND RISK BEHAVIOR: 
In our study the prevalence of STIs are more common in the age 
group of 20-30 years.(TABLE11) 
Age group STIs {Number (%)} 
<20 years 3 (11.1) 
20-30 years 19 (70.4) 
>30 years 5(18.5) 
P value is 0.03, which shows significance between 20-30 years of 
age and prevalence of STIs. 
 
The prevalence of STIs are more common in the patients who 
have completed secondary and higher secondary education and least in 
patients who have completed degree.(TABLE-12) 
Education STIs {Number (%)} 
<8th std 7(25.9) 
8th – 12th std 17(63.0) 
>12th std/degree 3(11.1) 
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The prevalence of STIs are more common in individual indulged 
in selling sex (male sex worker {MSWs}) than with other 
occupations.(TABLE-13) 
Occupation STIs {Number (%)} 
House keeping 2 (7.4) 
Coolie 9(33.3) 
MSWs 11(40.7) 
Others  5(18.5) 
P value is 0.056, which shows no significance between MSWs 
and prevalence of STIs among them in our study. This is consistent with 
other studies because of low sample size.  
The prevalence of STIs are more common in unmarried 
individuals than in married individuals. (TABLE-14) 
Marital status STIs {Number (%)} 
Unmarried 21(77.8) 
Married 6(22.2) 
The prevalence of STIs associated with following risk factors: 
(TABLE-15), (FIG-15) 
Risk factors STIs {Number } 
Smoking  20 
Alcohol  22 
I.V.Drug abuse 7 
Jaundice  3 
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STIs are more common in alcoholics followed by smokers. 
P value for alcohol and prevalence of STIs is 0.04, which shows 
significance between alcohol intake and prevalence of STIs which 
proves that alcohol is a major risk factors. Other risk factors showed no 
significance with p value > 0.05. 
The prevalence of STIs are more common in patients who had 
recent sexual exposure within 1month. The most common being 
genital/perianal wart followed by gonococcal urethritis. (TABLE-16) 
Recent exposure STIs {Number (%)} 
< 1month 17 
1-6 months 7 
6months-2years 3 
>2years 0 
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The prevalence of STIs are more common in individuals who had 
initial sexual exposure at the age group of 16-20 years.(TABLE-17) 
Initial exposure (age) STIs {Number (%)} 
<16 years 0 
16-20years 14 (51.9) 
21-25 years 12 (44.4) 
26-30 years 1(3.7) 
>30years 0 
P value is 0.424 showing no significance between early sexual 
exposure and increased prevalence of STIs in our study. This is in 
consistent with other studies because of low sample size.  
 
The prevalence of STIs is more common among patients who had 
exposure with  unknown partner than among known partner , STIs were 
also common among those who had irregular partners.(TABLE-18) 
Partner status STIs {Number (%)} 
Unknown 21 (77.8) 
Known  6 (22.2) 
P value is 0.008, which shows significance between sexual contact 
with unknown partner and prevalence of STIs.  
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The prevalence of STIs are more common in the patients who did 
not use condom during their recent exposure and who gave history of 
irregular usage of condom. Among them condom had been used most 
commonly during ano and oro insertive route.(TABLE-19) 
Condom usage STIs {Number (%)} 
Yes 7(25.9) 
No 20 (74.1) 
 
The prevalence of STIs are more common in anoreceptive 
individuals followed by ororeceptive, oroinsertive, anoinsertive and 
intracrural. (TABLE-20), (FIG-16) 
Route of sex STIs {Number (%)} 
Ano-receptive 15 (55.5) 
Oro-receptive 13 (48.1) 
Oro-insertive 12 (44.4) 
Ano-insertive 9 (33.3) 
Intra-crural 4 (14.8) 
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P value for all routes is > 0.05 showing no significance between 
route of sex and prevalence of STIs. 
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DISCUSSION 
In our study most common age group found between 20 - 30 
years(64%). It is consistent with study done by Arpit C. Prajapati et al
59 
where the most common age group was between 25-35 years. As in this 
age group , young MSM increasingly engage in high risk sexual 
behavior like unprotected anal sex, lack of awareness of STIs, multiple 
sex partners and they use the internet to recruit sex partners which leads 
on to increased transmission of STIs
60
. CDC(Centre for Disease Control 
and prevention) estimated that each year 19 million new infections 
occur, almost half of them belong to age group of 15 to 24
61
. This is 
because of increase in screening efforts, case reporting and usage of 
more sensitive diagnostic tests, but it also reflects an actual increase in 
STIs. 
In our study, more than half (63%) of all MSMs had completed 
secondary and higher secondary education.  Harshal R. Salve et al
62
 
have reported to have highest number of MSMs completed matriculation 
and higher studies. In Chennai Saravanamurthy, et al. reported 59% had 
basic education (6th-12th grade(59%)
63
. 
In our study 9% of MSMs are illiterate unlike Arpit C. Prajapati et 
al
59 
where illiteracy rate among study population was (19.3%). In our 
study, the prevalence of STIs are more among population who have 
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completed secondary and higher secondary education (63%) and in 
illiterate it is (14.8%). 
In our study, 13% of the MSMs noted that sex work was their 
main source of income (MSWs), the rest were mostly either in 
housekeeping (50%) which also included students (9%), coolie/self -
employed (14%) or worked as others  (clerks/salesmen /driver/painter/ 
carpenter) (14%) which is corroborating with studies. In Arpit C. 
Prajapati et al
59 
study 7.2% of the MSMs noted to be male sex worker 
(MSWs). The prevalence of STIs are more common in individual 
indulged in selling sex (male sex worker {MSWs}) than with other 
occupations. Thus a significant proportion of MSWs are depended on 
sex work as a source of income. 
In our study, 47% were paid for sex and the prevalence of STIs 
were more common among MSMs who were paid for sex. In another 
study, 35.9% had ever paid another man for sex
69 
In our study 70% were unmarried and 30% were married.
.
 In 
similar type of study by Raja ram S, et al. reported 58.4% MSMs were 
unmarried, and 39.9% were married
64
. In Arpit C. Prajapati et al
59
 half 
of the MSM were married. In our study, The prevalence of STIs are 
more common in unmarried individuals and out of the total MSM 
patients, 11patients (11%) were homosexuals, whereas 89 (89%) were 
bisexuals. This married MSM serve as the bridge population in the 
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transmission of different sexually transmitted diseases including HIV 
epidemic
59
. Among the unmarried MSM, 40% of MSM wanted to marry 
with male gender and 6% of MSM did not want to marry at all. Almost 
36.9% of married MSMs had disclosed their sexual behavior to their 
wives. 
Corroborating with other studies , double-decker (49%) was the 
commonest sub-typology of MSM, followed by Kothis, TGs and Panthis 
(32%,13%,6%) respectively in our study. Supporting with other studies, 
the proportion of Panthis in our study is low. This could be because of 
hidden nature of this sub-typology. And also, these being the insertive 
partner, mostly they identify themselves as heterosexuals
65
. In an 
another study, 51.4% were double decker, 38.4% were kothis , 7.8% of 
TGs, and 1.4% were panthis
62
. 
In our study 77(77%) patients were alcoholic, 69(69%) were 
smokers, 12(12%) had history of intravenous drug abuse. The 
prevalence of STIs are seen in alcoholics is (81.5%).  Having Alcohol 
has been identified as important determinant of HIV-related risk 
behaviors in MSMs both nationally
66
 and internationally
67,68
. In study 
done by Harshal R. Salve et al
62
 48% were alcoholics but regular use of 
alcohol was seen in 45.2%. In a study from Chennai estimated  28% of 
MSM using alcohol every week to the point of intoxication, tobacco use 
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weekly
69
. The alcohol consumption impairs judgment during sexual 
intercourse and decreases the likelihood of condom usage
70
. 
The initiation of sexual act is most common in  the age group of 
16-20 yrs (55%), followed by 21-25 yrs (32%). 4 patients had their first 
exposure at the < 16 yrs of age. Out of four , three had a history of child 
abuse. Early sexual introduction of the MSMs is an indicator of 
engaging with multiple sex partners and their vulnerability to STIs. 
Earlier the exposure, more the duration of sex strongly associated with 
HIV and other STIs in other studies which is not found in our study .  In 
another study the first sexual act was found more common in age group 
of 10-19 years (68%).The youngest age of first sex in MSMs was found 
to be 7-8 years in 4 MSM as they were sexually abused
59
. Miche 
Rodolph, et al. reported the similar findings, where majority of MSMs 
had their first sexual act between the age of 16-18 in  Cambodia
71
.  In 
our study, the prevalence of STIs are more common in individuals who 
had initial sexual exposure at the age group of 16-20 years. 
With regards to the type of first sexual experience, (50.7%) of the 
MSMs reported anal sex as their first sexual act, with 37% and 8.3% 
reporting vaginally and masturbation or oral, respectively.  
Regarding status of partner, 53 patients had recent exposure with 
unknown partners and 47 had with known partners. The prevalence of 
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STIs is more common among patients who had exposure with  unknown 
partner than among known partner. 
In our study, of total, 64% had history of recent exposure within 1 
month duration , 23% patients had within past 1-6 months of duration. 
The prevalence of STIs are more common in patients who had recent 
sexual exposure within 1month. The most common being 
genital/perianal wart followed by gonococcal urethritis.  
In our study,65% patients gave history of condom usage at last 
sexual act. Condom use at last sex was relatively high for receptive anal 
sex (73.8%). In another study, condom use at last sexual act was 
relatively higher for anal receptive sex (89%) with male partner but it 
decreases for anal insertive sex with male and female to 79% and 39% 
respectively
72 
 which is corroborating with our study. In study done by 
Prabahar P et al
73
, only 7.16% gave the history of condom usage. In a 
study done in Chennai, 22% had unprotected anal sex
69
. 
In our study, the prevalence of STIs are more common in the 
patients who did not use condom during their recent exposure and who 
gave history of irregular usage of condom. Among used patients condom 
has been used most commonly during ano and oro insertive route. In one 
study , the assessment finding showed the improved accessibility of the 
condoms leads on to reduced risk behaviours with male sexual partners. 
There was decline in the prevalence of syphilis due to condom usage
74
. 
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The pattern of sex in our study is, the highest number  of patients 
were anorecetive (42%) followed by ororeceptive (40%) followed by 
oroinsertive (39%) followed by anoinsertive (29%) and least were 
indulged in intracrural (5%) which is supporting with other study done 
by Arpit C. Prajapati et al
1
 where 43.2% were involved in anoreceptive 
sex, 24.4% in anoinsertive and half of population in oral sex. The 
prevalence of STIs are more common in anoreceptive (55.5%) 
individuals. Anal intercourse specially receptive sexual partner is  at 
higher risk of contracting an STI from their penetrating partners. Half of 
the MSM were involved in oral sex also
59
. 
PREVALENCE OF STIS 
Out of 100 patients (MSMs) who attended the opd, 23 cases came 
with symptoms, 11 cases for self screening and 66 cases were bought by 
NGOs. After evaluation 27 (27%) patients were newly diagnosed with 
sexually transmitted infections like HIV, Syphilis, Herpes genitalis, 
Gonococcal-urethritis, Genital and perianal wart, Molluscum 
contagiosum, Balanoposthitis and Genital scabies.  
Among 27 newly diagnosed STIs , 4 (14.8%) cases were found to 
have HIV (all are positive for HIV-1),5 (18.5%) cases of syphilis ( 2 
cases with early syphilis and 3 cases with late syphilis),7 (26%) cases of 
genital and perianal wart, 4 (14.8%) cases of gonococcal urethritis, 2 
(7.4%) cases of molluscum contagiosum (MC), 2 (7.4%) cases of herpes 
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genitalia, 2 (7.4%) cases hepatitis B and 1 (3.7%) case of genital 
scabies. In study done by Prabahar P et al
73
, the prevalence of STIs 
found to be 13.25%. 
The prevalence of STIs are common among double decker. The 
total prevalence of STIs among 13 transgenders was 30.7% i.e 4 cases ( 
1 case (7.6%) had early syphilis, 1 case (7.6%) had perianal wart and 
other 2 cases (15.3%) were diagnosed with HIV-1). In study done by 
Subhash Dasarathan
74 
, the total prevalence of STIs among TGs was 
found to be 48.8%. TGs were found to have increased prevalence of 
STIs is due to poor health seeking behavior. This is due to 
misconception about STIs and fear of discrimination by health care 
person and stigma in the society and health care settings.  
In our study , wart was more common which is followed by 
syphilis, HIV, gonococcal urethritis, herpes genitalis, molluscum 
contagiosum, hepatitis B and genital scabies unlike study done by Taru 
Garg
76
 where syphilis was the most common followed by wart, herpes 
genitalis, and gonococcal urethritis.  In our study 2(7.4%) of 27 had 
mixed infection at the time of presentation. One had early syphilis and 
one had genital wart in previously diagnosed HIV patients respective ly. 
In Taru Garg
76
 study ,(11%) had mixed infection. 
Out of rest 73 patients in our study, 7 cases were old case of 
sexually transmitted infection and 7 had non venereal dermatoses that 
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contains balanoposthitis, pearly penile papules,. Out of 100, 59 were 
non diseased. 
SYPHILIS 
Total number of MSMs positive for Syphilis during routine RPR 
testing were 5 (18.5%) (SPAN)  which was then confirmed with T. 
pallidum hemagglutination assay (TPHA) . Of the 5 positive MSM 
patients, 2(40%) were diagnosed to have early syphilis and 3 (60%) 
were diagnosed to have late latent syphilis. In patients with early 
syphilis one dose inj. Benzathine penicillin 2.4 million units is given 
and in late syphilis 3 doses of inj. Benzathine penicillin 2.4 million units 
is given and advised for follow up. There was decline in 4 fold dilution 
among 3 patients at 3 months. Patients were asked to bring partner. In 
another study, prevalence of syphilis among MSMs was found to be 
(4.5%) out of which 47.3% diagnosed to have early syphilis and 52.7% 
were diagnosed to have late syphilis
73
. In study done by Prakash 
Narayanan
72
, the prevalence of syphilis among MSMs was 6.6% which 
lesser when compared to our study. 
In our study, 1 case of early syphilis is seen in the already 
diagnosed HIV patient. In a study done in Mumbai showed that HIV 
positives are 2.4 times more at risk of getting syphilis during their life 
time
77
. In our study, 1(7.6%) case of early syphilis was seen in 
transgender (TGs). In a study done by Subhash Dasarathan
75
, in 20.7% 
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of TGs were affected by syphilis and it was the most common STI 
among other STIs which is not in concordance with our study. This may 
be due to low number of TGs included in the study.  
HIV 
HIV infection among men who have sex with men (MSM) has been 
increasing in recent years around the world, particularly in Asia
78
.The 
prevalence of newly diagnosed HIV is 14.8% during the routine 
investigation which was confirmed with 2
nd
 and 3
rd
 HIV kit (HIV1+2 
immunodot test kit , ½ trispot kit ,SD BIOLINE). Patients were referred to 
ART center for further management and asked to bring partner for check 
up. In other studies the prevalence of HIV among MSMs were 4%
76
, 17%
79 
,19.2%
73
 35.6%
72
. In study done Setai et al, the prevalence was 16.5% 
which is in consistent with our study. NACO reported prevalence of HIV 
among MSM in Chennai is 6.8% and in Mumbai is 9.6%
79
. 
In our study 3 out 4 cases of HIV had unprotected anoreceptive 
sex. Unprotected  anoreceptive intercourse has been described as an 
independent risk factor for HIV infection among MSM
60,80
. One recent 
study estimated the risk of HIV infection in anoreceptive intercourse per 
act with a HIV positive partner is 0.82% and with a unknown serostatus 
partner is 0.27%
36
. 
Transgenders are 49 times more at risk of living with HIV/AIDS 
compared to general population. In present study, 2 out of 4 i.e 50% 
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prevalence was seen in TGs. In another study on TGs the prevalence was 
13.4%
75
, 18.1%
81
 ,68%
79
. 
In our study one case of HIV positive patients give history of I.V 
drug abuse. I.V drug abuse is the main risk factor for HIV in north-east 
India. In 2006, NACO reported 2.4-19.8% of HIV infection among I.V 
drug users in north-eastern states, 16.8% in Chennai ,10% in New Delhi, 
20.4% in Mumbai
82
. 
HPV 
Human papillomavirus (HPV) infection among MSM is the 
primarly a risk factor for anal cancer and the rate is much higher than 
the general population,and trends suggesting increasing rates, 
particularly among HIV-infected MSM. 
In our study the prevalence is 26%. It is the most common STI 
noticed in MSM in our study. 2 (28.5%) out 7, had penile wart, 3 
(42.8%) had perianal wart and 2 (28.5%) had both penile and perianal 
wart which were treated with podophyllin toxin and cryotherapy . In 
another study, the prevalence was 26% and out of total, 50% had penile 
warts, 37.5% had perianal warts and 12.5%had both penile and perianal 
warts
 
. All patients with perianal warts gave history of being passive 
partners, and thereby indulging into unprotected anoreceptive 
intercourse
76
 similar to present study. 
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HPV infection among MSM is highest in those who are coinfected 
with HIV
83
. In present study, one case of genital wart was diagnosed in 
previously diagnosed HIV patient.  In our study, the prevalence of wart 
among TGs is 7.6% (1 case of perianal wart). In another study the 
prevalence was 2.43%
75
. 
HSV 
It is one of the most prevalent sexually transmitted infection 
globally including India. In our study 2 (7.4%) cases of herpes genitalis 
were found, both cases came with primary episode which were treated 
with red kit (kit5) and asked to bring partner for screening .11 cases 
were positive for HSV 2 and 15 cases were positive for HSV 1. In a 
study done in Mumbai in 2003, 26% of MSWs were found to be HSV-2 
seropositive
77
 which is not correlating with our study. In a study done 
2001 in Mumbai, 40% of MSM were positive for HSV 2 IgG
79
. In 
another study 1% (12 cases) had herper genitalis of which 7 patients had 
primary episode and 5 had recurrent episode
73
. 
In present study. Out of 2 ,1 (3.7%) was seen in transgender. 1 
(3.7%) presented with herpes genitalis . In other studies 71% of 
transgenders were found to be positive for HSV 2 IgG
79
. In other studies 
the prevalence of HSV-2 in TGs is 45.4%
81
, 29%
77
. 
Increase in the HSV-2 prevalence highlights about large number 
of undiagnosed patients and the presence of asymptomatic shedding.  
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URETHRITIS 
In our study, out of the 4 MSM patients who had urethritis, all 4 
(14.8%) were due to gonococcal infection. Gonococcal urethritis was 
diagnosed by Gram stain and culture and treated with grey kit (kit1) and 
epidose was given for partners. There was no evidence of rectal 
involvement in our study. In one study the prevalence among MSMs was 
13.8%
59
 which is in consistent with our study. In present study it was 
seen more common in patients who had sexual exposure within a week 
with unknown partner , , no case of non-gonoccal urethritis or rectal 
discharge were seen. 
HEPATITIS B AND C 
Infections caused by hepatitis B virus (HBV) and hepatitis C virus 
(HCV) show an increasing trend among high risk groups. In our study, the 
prevalence was 7.4% (2 cases), out of which one case was positive for only 
HBsAg and another case was positive for both HBsAg and anti HCV. 
Prevalence among MSMs is - 4.4% and 3.3% for HBV and HCV 
respectively
84
. In other studies, it was 8%
63 
and 21%
79
 for HBV. HBsAg 
prevalence of 90% among MSM and 20% among transgenders was 
reported from Mumbai in 2001
79
. 
One cases with both HBsAg and HCV positive is seen in I.V.Drug 
abuse. Hepatitis C infection is very high among IDUs, the highest being 
reported from the North Eastern states of the country
85
. 
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This suggests that the contaminated injections are the 
predominant mode of transmission of hepatitis C, unlike hepatitis B, 
where sexual transmission also plays an important role. In sp ite of the 
availability of vaccines, prevalence of HBsAg remains higher in India, 
because hepatitis B vaccination is not a part of our national 
immunization schedule. In our study 9 cases were vaccinated with 
HBsAg vaccination. 
MOLLUSCUM CONTAGIOSUM 
The prevalence of genital MC (molluscum contagiosum) has also 
increased. In present study 7.4 % (1case)  were positive for MC. He was 
treated by doing needling and removal of the molluscum bodies from the 
lesion. There is significant rise from 1% to 9.8% from 1970 to 2000 in a 
study done in North India86. In Andhra Pradesh, the genital MC cases 
showed a 2-fold rise from 0.22% to 0.31%
87
 from 2000 to 2005. 
GENITAL SCABIES 
In our study the prevalence was 7.4% (1 case) who presented with 
the multiple itchy papules over penis and scrotum and treated with 1% 
GBHC( gamma benzene hexachloride), overnight application and wash 
in the morning and asked to bring the partner for treatment. In a study 
7(0.57%)
73
 and 4.4%
76
 had genital scabies. The incidence is higher in 
MSMs than general population
73.
 This may be due unhygienic  practices 
among MSMs and poor health seeking behavior.  
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CLINICAL PICTURES 
PERIANAL & PENILE WARTS 
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CONCLUSION 
 MSM are the ―bridging population for spread of  STIs and HIV 
 The prevalence of STIs in MSM is seen in 2nd decade of age. 
 Higher secondary educated MSMs are more prone for acquiring 
STIs. 
 Increased prevalence is seen in unmarried MSMs with unknown 
partners. 
 Age of onset of sexual intercourse is earlier among MSMs. 
 Most common route of sexual intercourse among MSMs found 
was anoreceptive > ororeceptive. 
 Highest prevalence of STIs were seen in MSMs with receptive 
nature (anoreceptive> ororeceptive).  
 Increased prevalence of  STIs are seen in MSMs with no condom 
usage. 
 Alcohol is major risk factor among MSMs in acquiring STIs.  
 In our study, predominantly wart (genital & perianal) was seen 
among MSMs. 
 Increase in the trend of syphilis among MSMs was noticed. 
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 Herpes simplex infection is though clinically asymptomatic , but 
antibodies are seen in disproponately higher in MSMs.  
 Sex education is need to be given very earlier in MSM individual 
as earlier the age of sexual activity.  
 Address the stigma among MSMs and increase the health care 
awareness among them. 
 Partner notification treatment needs to be encouraged.  
 Hepatitis B vaccination should be promoted.  
 Counselling for consistent use of condom should be done 
intensively to improve condom use special with unknown partners 
and during oral sex. 
 Promoting awareness regarding HIV-AIDS transmission & its 
prevention may sensitize them to use condom correctly during 
every sexual act. 
 Much more work is needed to determine how to best help MSM 
minimize sexual risk, address mental health concerns, and engage 
in healthy lives. 
 Regular monitoring of program data and operational research are 
necessary for further effectiveness of prevention and control of 
HIV in this HRG. 
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PROFORMA  
 
NAME OF THE PATIENT  :                                           AGE /SEX: 
ADDRESS: 
OCCUPATION : 
PH.NO.: 
SOCIO-ECONOMIC STATUS :  
EDUCATION: 
 
MARIATAL STATUS : 
 
COMPLAINTS OF  
 
PAST H/O : 
 
SEXUAL HISTORY: 
Recent exposure 
Contact history 
MSM activity  
 
FAMILY HISTORY: 
 
PERSONAL HISTORY: 
 
EXAMINATION: G/E: 
 
25 
GENITAL  EXAMINATION: 
 
 
 
 
DIAGNOSIS: 
 
INVESTIGATIONS: 
 
HIV 1 AND 2 
RPR 
TPHA 
HBsAg 
Anti HCV 
HSV 1 and 2 
 
 
26 
CONSENT FORM 
Mr :   
Age : 
Address : 
Phone : 
Treatment given : 
I undersigned Mr                        
have  been explained about the risk of sexually transmitted infections 
due to MSM activity. I have been explained about the blood tests , being 
done to investigate the possibility sexually transmitted infections in my 
regional language. I am also aware that the test is only a diagnostic 
tests. The possible side effects are explained  . I have been explained   
that this study will be performed by Dr.Ashwini B 
I further state that I have carefully read and understood all the 
information provided in this form and with full conscious mind I hereby 
give my consent for the said investigation with its risks involved.  
 
Signature of the Patients/Thumb impression:  
 
 
 
Witness: 
Name:                                                                        Signature:  
Date: 
 
 
27 
PATIENT INFORMATION MODULE 
You are being invited to be a subject in this study.  
Before you participate in this study, I am giving   following details 
about this trial, which include the aims, methodology, intervention, 
possible side effects, if any . 
MSMs will be included in this study. A detailed clinical history will be 
taken following a standardized Performa. A clinical examination and 
relevant investigation will be done.  
The result arising from this study will be analyzed and used for 
academic purposes. You will be given clear instructions at every step 
and you are free to ask/clarify any doubts. Your identity remains 
confidential. You are free to withdraw from the trial at any point of 
time, without any prior notice &/or without any medical or legal 
implications. 
I request you to volunteer for this study 
     Thanking You 
 
 Investigator’s Sign     Patient’s Sign 
(Dr.Ashwini B)                                  Name: 
 
28 
 
 
29 
 
 
30 
KEY TO MASTER CHART: 
 MS marital status 
 HS house- keeping 
 COL coolie 
 MSW male sex worker 
 EDU educator 
 PVD previous venereal disease 
 PT presumptive treatment 
 Smo smoking 
 Alc alcohol 
 IVD intravenous drug abuse 
 B.T blood transfusion 
 Jau jaundice 
 R.exp recent sexual exposure  
 Int.Exp age at intial exposure 
 SOP status of partner 
 CON condom usage 
 AR anoreceptive 
 AI anoinsertive 
 OR ororeceptive 
 OIoroinsertive 
 IC intercrural 
 GE genital examintion 
 Sod soddening 
 Chan chancre 
 RS reconstructive surgery 
 HU herpetic ulcer 
 Syp- syphilis 
 UK unknown 
 K known 
 0  no 
 1 yes 
 
MASTER CHART 
 
 
 
 
S.no Age edu occu M.S REASON PVD P.T Smo Alc IVD BT Jau R.Exp Int.expSOP CON PAID AR AI OR OI IC GE RS Diagnosis HIV 1&2 RPR TPHA HBsAg A.HCV
1 20 10th HS UM   NGO NO YES YES YES NO NO NO 10days 16 UK YES YES 1 1 1 1 0 n no scr neg neg neg neg neg
2 43 8th HS UM NGO NO YES YES YES NO NO NO 11days 16 K NO NO 0 1 0 1 0 n yes scr neg neg neg neg neg
3 36 10th HS M     NGO NO YES YES YES NO NO NO 12days 16 K NO NO 1 0 1 0 0 n no scr neg neg neg neg neg
4 45 9th HS UM   itching over genitalia NO NO YES YES YES NO NO 13days 16 K YES NO 1 0 0 0 0 sod no BP neg neg neg neg neg
5 26 UE COL UM NGO NO NO YES NO NO NO YES 10days 17 K NO NO 1 0 1 0 0 n yes scr neg neg neg neg neg
6 25 10th HS M     NGO NO YES YES YES NO NO NO 2mths 20 K YES no 1 1 0 0 0 h'roids no scr neg neg neg neg neg
7 27 5th MSW M     NGO HG YES NO NO NO NO NO 10days 17 UK NO YES 0 0 1 0 1 erosion no old HU neg neg neg neg neg
8 28 12th MSW UM  NGO SYP NO NO YES NO NO NO 2yrs 20 UK YE yes 1 0 1 0 0 n no  old syp neg 1:2dil neg neg neg
9 36 8th COL UM NGO NO NO YES YES NO NO YES 3yrs 25 UK NO no 1 0 1 0 0 n yes scr neg neg neg neg neg
10 22 12th HS UM   NGO NO NO YES YES NO NO NO 1day 19 UK YES no 0 1 1 1 0 n no scr neg neg neg neg neg
11 25 10th COL M     NGO NO YES NO YES NO NO NO 15days 18 K YES YES 1 0 1 0 0 n no scr neg neg neg neg neg
12 20 10th COL UM   NGO NO YES YES NO NO NO NO 1day 17 UK YES NO 1 0 1 0 1 n no scr neg neg neg neg neg
13 29 BEd MSW UM  self screening NO YES YES NO NO YES NO 3days 20 UK NO YES 0 0 1 0 0 n yes scr neg neg neg neg neg
14 37 12th HS M     NGO LLS YES NO YES NO NO NO 1week 17 UK YES YES 1 0 1 0 0 n no  old HIV/LLS pos neg neg neg neg
15 25 8th HS M     NGO NO NO YES YES NO NO NO 6mths 14 K YES NO 1 0 1 0 0 n no scr neg neg neg neg neg
16 27 10th MSW UM  NGO NO NO YES YES YES NO NO 18mths 20 UK NO YES 1 0 0 0 0 n yes HIV pos neg neg neg neg
17 23 5th COL M     NGO NO NO YES YES NO NO YES 10days 15 K NO no 1 0 1 1 0 n no scr neg neg neg neg neg
18 34 10th HS M     NGO NO NO YES NO NO NO NO 3yrs 12 UK YES YES 1 0 1 0 1 n no scr neg neg neg neg neg
19 26 10th HS UM NGO NO NO YES YES NO NO NO 18mths 20 K YES no 1 0 0 0 0 n yes scr neg neg neg neg neg
20 28 8th COL M     NGO NO YES YES YES NO NO NO 1day 20 UK NO YES 0 0 1 0 0 n no scr neg neg neg neg neg
21 35 6th MSW UM  NGO NO NO YES YES NO NO NO 1wk 18 UK YES yes 1 0 0 0 0 n no HIV pos (1) neg neg neg neg
22 24 dip MSW UM   NGO NO YES YES YES NO NO NO 1day 20 UK YES yes 0 0 1 1 0 n no scr neg neg neg neg neg
23 31 10th COL M     genital ulcer NO NO YES YES NO NO NO 1wk 20 K NO NO 1 0 1 0 0 chan no syp (plha) pos 1:8 dil pos neg neg
24 42 3rd COL UM   NGO NO YES NO NO NO NO NO 2wks 18 K YES NO 1 0 1 1 0 n no scr neg neg neg neg neg
25 22 3rd COL M     NGO NO YES YES YES NO NO NO 3wk 20 K YES YES 0 0 1 0 0 n no scr neg neg neg neg neg
26 26 8th EDU M     self screening NO YES YES YES NO NO NO 6wks 22 UK NO YES 0 0 0 1 0 n no scr neg neg neg neg neg
27 38 8th MSW M     NGO NO YES YES YES NO NO NO 8yr 18 UK NO YES 0 0 0 1 0 n no scr neg neg neg neg neg
28 37 8th COL UM    self screening NO YES YES YES NO NO NO 1mth 17 K YES no 0 0 1 1 0 n no scr neg neg neg neg neg
29 21 12th MSW M     NGO NO YES YES YES NO NO NO 1week 16 UK NO YES 1 0 1 0 0 n no scr neg neg neg neg neg
  
 
 
30 22 8th MSW UM   SELF SCREENING NO YES NO NO NO NO NO 1dco 20 K YES YES 1 0 1 0 0 n no scr neg neg neg neg neg
31 34 8th MSW M     growth over genitalia NO NO YES NO NO NO NO 6days 22 K NO YES 0 0 0 0 0 grw no  wart (plha) neg neg neg neg neg
32 22 dip EDU UM   self screening NO YES NO YES NO NO NO 1day 18 K YES no 0 0 1 1 0 n yes scr neg neg neg neg neg
33 40 5th OTHERS M     burning micturitation  NO YES NO NO NO NO NO 2mths 20 UK YES YES 1 0 0 0 1 n no uti neg neg neg neg neg
34 22 dip HS UM    NGO PAW NO NO NO NO NO NO 6weeks 18 K NO no 1 0 1 0 0 n yes scr neg neg neg neg neg
35 19 10th COL UM NGO NO NO YES NO NO NO NO 1day 17 K YES no 0 0 1 0 0 n no scr neg neg neg neg neg
36 20 10th MSW M     NGO NO YES NO NO NO NO YES 2day 17 UK NO YES 0 0 0 1 0 n no scr neg neg neg neg neg
37 27 8th HS M     NGO NO YES YES YES NO NO NO 1wk 20 K YES NO 1 1 1 1 0 n no scr neg neg neg neg neg
38 46 B.ed EDU M     NGO NO YES YES NO NO NO NO 9yrs 25 K YES YES 1 0 1 0 0 n no scr neg neg neg neg neg
39 35 4th MSW UM NGO NO NO NO YES NO NO NO 3yr 28 UK YES YES 0 1 0 1 1 n no scr neg neg neg neg neg
40 44 12th COL UM   itching over genitalia NO YES NO YES NO NO NO 1day 17 UK NO no 0 0 1 0 0 sod no BP neg neg neg neg neg
41 20 4th COL M     NGO NO YES NO YES YES NO NO 3days 15 K YES NO 1 0 1 0 0 n no PLHA pos (1) neg neg neg neg
42 23 B.cm MSW UM   NGO NO NO YES YES NO NO NO 1month 24 UK YES YES 0 0 1 0 1 P&S no syp neg 1: 4 dil pos neg neg
43 24 UE MSW UM urethral discharge NO NO YES NO YES NO NO 1week 24 UK NO yes 0 1 1 0 0 n no Go.Ur neg neg neg neg neg
44 33 UE COL UM    NGO NO YES NO YES NO NO NO 1day 22 UK YES NO 1 0 0 0 0 n yes scr neg neg neg neg neg
45 21 12th OTHERS UM   self screening NO YES NO NO NO YES NO 2yrs 20 UK YES no 1 0 1 0 0 n no scr neg neg neg neg neg
46 39 10th COL M     NGO NO YES NO NO NO NO NO 1wk 18 UK NO NO 0 0 0 0 1 n no scr neg neg neg neg neg
47 22 10th EDU M     urethral discharge NO NO YES YES NO NO NO 1wk 19 UK NO NO 1 0 1 1 0 MPUD no Go.Ur neg neg neg neg neg
48 40 8th COL M     NGO NO YES YES YES NO NO NO 4months 20 K YES NO 0 1 1 1 0 n no scr neg neg neg neg neg
49 34 6th OTHERS M     NGO NO YES YES YES NO NO NO 3days 20 UK YES no 1 1 1 1 0 n no scr neg neg neg neg neg
50 34 10th MSW M     NGO NO YES YES YES YES NO NO 2weeks 22 K NO no 0 1 0 0 0 n no scr neg neg neg neg neg
51 21 4th COL M     papules over genitalia NO NO NO YES YES NO NO 3weeks 19 K YES NO 0 1 0 0 0 pap no MC neg neg neg neg neg
52 32 10th OTHERS M     NGO NO YES YES YES NO NO NO 20days 23 UK YES YES 0 0 1 1 1 n no scr neg neg neg neg neg
53 25 9th OTHERS UM    NGO NO YES NO YES NO NO NO 20days 20 UK NO YES 0 0 1 1 0 n no scr neg neg neg neg neg
54 30 8th OTHERS M     NGO NO YES NO YES YES NO NO 10days 30 UK YES no 0 0 0 1 0 n no scr neg neg neg neg neg
55 25 12th COL M     NGO NO NO YES YES NO NO NO 4months 23 UK NO no 1 0 0 0 0 n yes syp neg 1: 64dil pos neg neg
56 24 8th MSW UM    perianal growth NO NO NO YES NO NO NO 1wk 20 K NO YES 0 1 0 1 0 grw yes PAW neg neg neg neg neg
57 36 10th COOLIE UM     itching over genitalia NO NO YES YES NO NO NO 1week 35 K YES NO 0 1 1 1 0 pap no scabies neg neg neg neg neg
58 28 B.cm OTHERS UM     NGO NO YES YES YES NO NO NO 1year 25 K NO NO 0 0 1 1 0 n no scr neg neg neg neg neg
59 22 12th OTHERS UM    genitalia growth NO NO YES YES NO NO NO 3weeks 20 UK NO NO 0 1 0 0 0 grw no wart neg neg neg neg neg
60 37 10th COL UM papules over genitalia NO NO YES YES NO NO YES 5mths 24 K YES NO 0 1 1 1 1 pap no ppp neg neg neg neg neg
61 36 B.cm EDU UM    papules over genitalia NO NO YES YES NO NO NO 1week 21 K YES YES 1 0 0 0 0 pap no ppp neg neg neg neg neg
62 29 10th COL M     genital ulcer NO NO YES YES YES NO NO 2mnths 22 UK NO NO 1 0 1 0 0 chan no syp neg 1: 256 dilpos neg neg
63 29 5th MSW UM    NGO NO NO YES YES NO NO NO 1month 20 UK YES YES 0 1 1 0 1 n no scr neg neg neg neg neg
64 22 B.cm COL UM   NGO NO YES YES YES YES NO NO 1day 18 K NO YES 1 0 1 0 0 n yes scr neg neg neg neg neg
65 27 10th MSW UM  NGO NO YES YES YES NO NO NO 10days 20 K NO NO 1 0 0 0 0 n no scr neg neg neg neg neg
  
 
66 28 10th OTHERS UM   NGO NO NO YES YES YES NO YES 2weeks 21 UK NO YES 1 1 1 0 0 n no hep B neg neg neg pos neg
67 34 5th HS UM     NGO NO YES YES YES NO NO NO 20days 32 K YES NO 0 0 0 1 1 n no scr neg neg neg neg neg
68 23 8th MSW UM     genital ulcer NO NO YES YES NO NO NO 2weeks 18 UK NO YES 1 1 0 1 0 G.U no HG neg neg neg neg neg
69 25 10th COL UM     NGO NO YES YES YES NO NO NO 3months 20 K NO NO 0 0 1 0 0 n no scr neg neg neg neg neg
70 24 B.cm EDU UM     self screening NO YES YES YES NO NO NO 2months 22 K YES YES 0 0 1 0 0 n no scr neg neg neg neg neg
71 27 10th COL UM     NGO NO NO YES NO NO NO NO 10days 23 UK NO NO 1 0 0 0 1 n yes HIV pos (1) neg neg neg neg
72 33 9th COL UM     scaly lesions-palms & solesG.U NO YES YES NO NO NO 1 weeks 25 UK NO YES 0 1 1 1 0 scar no syp neg 1:32 dil pos neg neg
73 25 B.Ed EDU UM     self screening NO NO NO YES NO NO yes 3months 22 UK YES YES 0 1 1 1 0 n no scr neg neg neg neg neg
74 43 10th OTHERS UM     NGO NO YES YES NO NO NO NO 3 months 22 K YES NO 0 1 0 0 0 pap no PPP neg neg neg neg neg
75 25 5th COL UM     growth over genitalia NO NO NO YES NO NO YES 2weeks 23 UK NO NO 1 0 1 0 0 grw yes PAW neg neg neg neg neg
76 29 5th OTHERS UM NGO NO YES NO YES NO NO NO 6months 21 UK NO NO 0 0 0 1 1 n no scr neg neg neg neg neg
77 22 8th OTHERS UM     NGO NO YES NO YES NO NO NO 6months 18 K YES NO 0 0 1 0 0 pap no ppp neg neg neg neg neg
78 27 10th OTHERS UM     NGO NO YES NO YES NO NO NO 20days 25 K YES NO 0 0 0 0 0 n no scr neg neg neg neg neg
79 21 B.cm MSW UM urethral discharge NO NO NO YES NO NO NO 20days 24 uk NO YES 1 1 0 0 1 MPUD no Go.Ur neg neg neg neg neg
80 19 7th OTHERS  UM     self screening NO YES YES YES YES YES YES 1month 18 UK YES YES 0 0 0 1 0 n no hep B neg neg neg pos pos
81 28 B.cm OTHERS  UM     NGO NO YES YES YES NO NO NO 2months 21 K NO YES 1 0 1 0 0 n no scr neg neg neg neg neg
82 26 8th OTHERS  UM     NGO NO YES YES YES NO NO NO 6months 17 UK NO NO 1 0 1 0 0 n no scr neg neg neg neg neg
83 35 12th OTHERS  UM     NGO NO NO YES YES NO NO NO 15days 32 UK YES NO 0 1 0 0 0 n no PLHA pos neg neg neg neg
84 18 5th HS  UM     perianal growth NO NO YES NO NO NO NO 3months 17 UK NO YES 1 0 1 0 1 grw no PAW neg neg neg neg neg
85 29 12th OTHERS  UM     NGO NO YES YES NO NO NO NO 2day 22 K YES NO 0 1 0 1 0 n no scr neg neg neg neg neg
86 28 8th COL  UM     NGO NO YES NO NO NO NO NO 3days 21 UK YES NO 1 0 1 0 0 n no scr neg neg neg neg neg
87 34 B.cm EDU  UM     NGO NO YES YES YES NO NO NO 2weeks 20 UK NO YES 0 1 1 0 1 n no scr neg neg neg neg neg
88 23 12th OTHERS  UM     growth over genitalia NO NO NO YES NO NO NO 4months 20 UK YES YES 1 1 0 1 0 grw no wart neg neg neg neg neg
89 36 BSc EDU UM NGO NO YES YES YES NO NO NO 2weeks 25 K YES NO 0 0 0 0 0 n yes scr neg neg neg neg neg
90 28 5th MSW UM      vesicles  over genital NO NO NO NO NO NO NO 10days 17 UK NO YES 0 0 1 1 0 G.U no HG neg neg neg neg neg
91 27 12th HS UM NGO LLS YES NO YES NO NO NO 1week 17 UK YES YES 1 0 0 0 1 n no old lls neg 1:8 dil neg neg neg
92 22 B.ed EDU UM      NGO NO YES YES NO NO NO NO 9yrs 25 K YES YES 0 1 1 1 1 n yes scr neg neg neg neg neg
93 19 10th COL UM      urethral discharge NO NO YES YES NO NO NO 1wk 18 UK NO NO 1 0 0 1 0 MPUD no Go.Ur neg neg neg neg neg
94 28 12th MSW UM NGO NO YES YES YES NO NO NO 2years 22 K YES NO 0 1 1 0 1 n no scr neg neg neg neg neg
95 23 12th MSW UM      growth over genitalia NO NO NO YES NO NO NO 2months 20 UK NO yes 1 0 1 1 0 grw no wart neg neg neg neg neg
96 21 10th HS UM papules over genitalia NO NO YES YES NO NO NO 3months 20 K YES NO 0 0 0 1 0 pap no MC neg neg neg neg neg
97 33 B.cm EDU UM self screening NO YES YES YES NO NO NO 2months 22 K YES YES 0 0 1 0 0 n no scr neg neg neg neg neg
98 24 10th OTHERS UM NGO NO YES YES YES NO NO NO 1wk 20 UK YES NO 0 0 0 1 0 n yes scr neg neg neg neg neg
99 26 8th HS UM NGO HG YES YES YES NO NO NO 2weeks 18 UK NO YES 0 1 0 1 0 scar no  old herpes genetalisneg neg neg neg neg
100 37 10th MSW UM     NGO NO NO YES YES YES NO NO 18mths 20 UK NO YES 1 0 1 1 0 n no HIV pos (1) neg neg neg neg
